厄贝沙坦药物报告 irbesartan Drug Report · mg、150 mg或300 mg厄贝沙坦。推荐起始剂量为每次150 mg，每日1次，空腹或随餐服用均可。推荐起始剂量为每次150

2018/1/15 irbesartan Drug Report

https://db.yaozh.com/report/detailwap/?id=Z5mWamVj 1/62

药智数据 https://db.yaozh.com

厄贝沙坦药物报告irbesartan Drug Report

药物英文名 irbesartan

药物中文名厄贝沙坦

药物别名 Aprovel; BMS-186295

原研单位 Sanofi-synthélabo (Originator), Bristol-Myers Squibb (Licensee), Shionogi (Licensee)

全球最高状态 1997年批准上市

中国是否上市是

厄贝沙坦由赛诺菲（Sanofi）研发，首先于1997年8月27日获得欧洲药物管理局（EMA）批准，之后于1997年9月30日获得美国食品药品管理局（FDA）批准，于2008年4月16日获得日本医药品医疗器械综合机构（PMDA）批准。由赛诺菲在欧洲和美国上市，商品名分别为Aprovel和Avapro。厄贝沙坦是血管紧张素II受体（AT1亚型）拮抗剂，通过与AT1血管紧张素II受体选择性的结合，以阻断血管紧张素II所引起的血管收缩和醛固酮分泌作用。该药用于治疗成人原发性高血压，也可作为降压药物治疗方案的一部分，用于高血压和2型糖尿病成年患者的肾病治疗。Aprovel为口服薄膜衣片剂，每片含有75mg、150 mg或300 mg厄贝沙坦。推荐起始剂量为每次150 mg，每日1次，空腹或随餐服用均可。

结构式

化学名称：2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one

CAS登记号：138402-11-6

分子式：C25H28N6O

分子量：428.5372

ATC分类

摘要信息

药物概述

API信息

药理作用



C09CA04 心血管系统 > 作用于肾素-血管紧张素系统的药物 > 血管紧张素II拮抗药，单方 > 血管紧张素II拮抗药，单方

作用靶点

Angiotensin II AT-1 receptor antagonist

参考靶点

Type-1 angiotensin II receptor; Transcription factor AP-1

作用机制

Irbesartan is a nonpeptide tetrazole derivative and an angiotensin II antagonist that selectively blocks the bindingof angiotensin II to the AT1 receptor. In the renin-angiotensin system, angiotensin I is converted by angiotensin-converting enzyme (ACE) to form angiotensin II. Angiotensin II stimulates the adrenal cortex to synthesize andsecrete aldosterone, which decreases the excretion of sodium and increases the excretion of potassium.Angiotensin II also acts as a vasoconstrictor in vascular smooth muscle. Irbesartan, by blocking the binding ofangiotensin II to the AT1 receptor, promotes vasodilation and decreases the effects of aldosterone. The negativefeedback regulation of angiotensin II on renin secretion is also inhibited, but the resulting rise in plasma reninconcentrations and consequent rise in angiotensin II plasma concentrations do not counteract the bloodpressure–lowering effect that occurs. The action of ARBs is different from ACE inhibitors, which block theconversion of angiotensin I to angiotensin II, meaning that the production of angiotensin II is not completelyinhibited, as the hormone can be formed via other enzymes. Also, unlike ACE inhibitors, irbesartan and other ARBsdo not interfere with response to bradykinins and substance P, which allows for the absence of adverse effectsthat are present in ACE inhibitors (eg. dry cough).

申请号商标名活性成分剂型/给药途径批准时间申请机构

020757 AVAPRO IRBESARTAN TABLET;ORAL 1997-09-30 SANOFI AVENTIS US

077159 IRBESARTAN IRBESARTAN TABLET;ORAL 2012-03-30 TEVA PHARMS

203161 IRBESARTAN IRBESARTAN TABLET;ORAL 2012-09-27 DR REDDYS LABS LTD

203081 IRBESARTAN IRBESARTAN TABLET;ORAL 2012-09-27 AUROBINDO PHARMA LTD

079213 IRBESARTAN IRBESARTAN TABLET;ORAL 2012-09-27 ZYDUS PHARMS USA INC

203071 IRBESARTAN IRBESARTAN TABLET;ORAL 2012-09-27 PRINSTON INC

077466 IRBESARTAN IRBESARTAN TABLET;ORAL 2012-09-27 SANDOZ

200461 IRBESARTAN IRBESARTAN TABLET;ORAL 2012-09-27 MYLAN PHARMS INC

202910 IRBESARTAN IRBESARTAN TABLET;ORAL 2012-09-27 HETERO LABS LTD V

202254 IRBESARTAN IRBESARTAN TABLET;ORAL 2012-10-03 MACLEODS PHARMS LTD

090720 IRBESARTAN IRBESARTAN TABLET;ORAL 2012-10-12 WATSON LABS INC

090201 IRBESARTAN IRBESARTAN TABLET;ORAL 2012-10-15 WEST-WARD PHARMS INT

美国上市情况(21条) 隐藏

https://db.yaozh.com/atc?atc_num=C09CA04

https://db.yaozh.com/targets/7156.html

https://db.yaozh.com/fdadrug/972536.html














申请号商标名活性成分剂型/给药途径批准时间申请机构

201531 IRBESARTAN IRBESARTAN TABLET;ORAL 2012-10-15 LUPIN LTD

200832 IRBESARTAN IRBESARTAN TABLET;ORAL 2012-10-15 APOTEX INC

091236 IRBESARTAN IRBESARTAN TABLET;ORAL 2012-10-15 ALEMBIC PHARMS LTD

077205 IRBESARTAN IRBESARTAN TABLET;ORAL 2012-11-14 CIPLA LTD

203534 IRBESARTAN IRBESARTAN TABLET;ORAL 2015-02-23 JUBILANT GENERICS

204774 IRBESARTAN IRBESARTAN TABLET;ORAL 2015-12-07 SCIEGEN PHARMS INC

203020 IRBESARTAN IRBESARTAN TABLET;ORAL 2015-12-07 UNICHEM LABS LTD

203685 IRBESARTAN IRBESARTAN TABLET;ORAL 2015-12-10 AJANTA PHARMA LTD

206194 IRBESARTAN IRBESARTAN TABLET;ORAL 2016-06-14 HISUN PHARM HANGZHOU

编号药品名称活性成分剂型上市许可持有人获批时间

EMEA/H/C/000142

Karveairbesart

anSanofi-aventis groupe 1997-08-27

EMEA/H/C/000141

Aprovelirbesart

anSanofi Clir SNC 1997-08-27

EMEA/H/C/000786

Irbesartan BMSirbesart

anBristol-Myers Squibb Pharma EEIG 2007-01-19

EMEA/H/C/000785

Irbesartan Zentiva(previouslyIrbesartanWinthrop)

irbesartan

Sanofi-aventis groupe ? 2007-01-19

EMEA/H/C/001093

Irbesartan Tevairbesart

anTeva B.V. 2009-10-30

EMEA/H/C/002510

Sabervelirbesart

anPharmathen S.A. 2012-04-13

NL/H/1209/

Irbec 75 mgtabletten

irbesartan 75

mg

Tablet

Laboratorioa Liconsa SA 2008-09-30

NL/H/1209/


irbesartan 150

mg

Tablet

Laboratorios Liconsa SA 2008-09-30

欧盟上市情况(221条) 隐藏










https://db.yaozh.com/epyp/detail?type=ema&id=7797






https://db.yaozh.com/epyp/detail?type=hma&id=274511





NL/H/1209/


irbesartan 300

mg

Tablet


NL/H/1210/

Irbesartan Liconsa75 mg tabletten

irbesartan 75

mg

Tablet


NL/H/1210/


irbesartan 150

mg

Tablet


NL/H/1210/


irbesartan 300

mg

Tablet


NL/H/1208/

Artin 75 mgtabletten

irbesartan 75

mg

Tablet

Laboratorios Liconsa S.A. 2008-09-30

NL/H/1208/


irbesartan 150

mg

Tablet

Laboratorias Liconsa S.A. 2008-09-30

NL/H/1208/


irbesartan 300

mg

Tablet

Laboratorios Liconsa S.A. 2008-09-30

HU/H/0171/

Irbesartan Miklich150mg film-coated

tablets

irbesartan 150

mg

Filmcoated

tablet

Miklich Laboratorios S.L. Calle Cuevas Bajas,s/n - Of. 23, Edificio Picasso, 29004 Málaga

Spain2008-11-04

HU/H/0171/

Irbesartan Miklich75 mg film-coated

tablets

irbesartan 75

mg

Filmcoated

tablet


Spain2008-11-04

HU/H/0171/

Irbesartan Miklich300 mg film-

coated tablets

irbesartan 300

mg

Filmcoated

tablet


Spain2008-11-04

NL/H/1116/

Irbesartan Urquima300 mg

irbesartan 300

mg

Filmcoated

tablet

Uriach Group Av.Camí Reial 51-57 08184Palau-solità i Plegamans Barcelona-Spain

2008-12-02

NL/H/1116/


irbesartan 75

mg

Filmcoated

tablet


2008-12-02

NL/H/1116/


irbesartan 150

mg

Filmcoated

tablet


2008-12-02

















NL/H/1242/

Irbesartan Ranbaxy300 mg

irbesartan 300

mg

Filmcoated

tablet

Ranbaxy Belgium NV 2008-12-11

NL/H/1242/


irbesartan 75

mg

Filmcoated

tablet


NL/H/1242/


irbesartan 150

mg

Filmcoated

tablet


NL/H/1401/

Irbesartan Accord300 mg tablets

irbesartan 300

mg

Filmcoated

tablet

Accord Health care Limited Sage house, 319Pinner road, North Harrow HA1 4HF,

Middlesex United Kingdom 0208 863 1427Telefax: 0

2009-03-23

NL/H/1401/


irbesartan 75

mg

Filmcoated

tablet


Middlesex United Kingdom Telephone: 0208863 1427

2009-03-23

NL/H/1401/


irbesartan 150

mg

Filmcoated

tablet


Middlesex United Kingdom 0208 863 1427Telefax: 0

2009-03-23

AT/H/020

2/

Irbesartan Sandoz75 mg -

Filmtabletten

irbesartan 75

mg

Filmcoated

tablet

Sandoz GesmbH Biochemiestrasse 10 6250Kundl Austria

2009-04-22

AT/H/020

2/


Filmtabletten

irbesartan 75

mg

Filmcoated

tablet


2009-04-22

AT/H/020

3/

Irbesartan Hexal 75mg - Filmtabletten

irbesartan 75

mg

Filmcoated

tablet

Hexal Pharma GmbH Stella-Klein-Löw-Weg 171020 Wien Austria

2009-04-22

AT/H/020

3/

Irbesartan Hexal150 mg -

Filmtabletten

irbesartan 150

mg

Filmcoated

tablet


2009-04-22














AT/H/020

4/


irbesartan 75

mg

Filmcoated

tablet

Hexal Pharma GmbH Carlberggasse 44 1235Wien Austria

2009-04-22

AT/H/020

4/


Filmtabletten

irbesartan 75

mg

Filmcoated

tablet


2009-04-22

AT/H/020

5/

Irbesartan Lek 75mg - Filmtabletten

irbesartan 75

mg

Filmcoated

tablet

Lek Parmaceuticals d.d. Verovskova 57 1526Ljubljana Slovenia

2009-04-22

AT/H/020

5/


irbesartan 150

mg

Filmcoated

tablet


2009-04-22

AT/H/020

5/


irbesartan 300

mg

Filmcoated

tablet


2009-04-22

AT/H/020

6/

Irbesartan Rowex75 mg -

Filmtabletten

irbesartan 75

mg

Filmcoated

tablet

Rowex Ltd Bantry, Co Cork Irland 2009-04-22

AT/H/020

3/


Filmtabletten

irbesartan 300

mg

Filmcoated

tablet


2009-04-22

AT/H/020

4/


irbesartan 75

mg

Filmcoated

tablet


2009-04-22

AT/H/020

6/

Irbesartan Rowex150 mg -

Filmtabletten

irbesartan 150

mg

Filmcoated

tablet

Rowex Ltd Bantry, Co Cork Irland 2009-04-22

AT/H/020

2/


Filmtabletten

irbesartan 300

mg

Filmcoated

tablet


2009-04-22














IT/H/0377

/Sykratan

irbesartan 75

mg

Filmcoated

tablet

Biomed Pharma S.r.l. Via Colla 6/3 17014 CairoMontenotte (SV) Italy

2009-05-14

PT/H/087

4/

IrbesartanAurobindo

irbesartan 75

mg

Filmcoated

tablet

Actavis Group PTC ehf Reykjavikurvegi 76-78220 Hafnarfjordur Iceland

2009-05-14

PT/H/087

4/

IrbesartanAurobindo

irbesartan 150

mg

Filmcoated

tablet


2009-05-14

PT/H/087

4/

IrbesartanAurobindo

irbesartan 300

mg

Filmcoated

tablet


2009-05-14

EE/H/011

2/Irprestan

irbesartan 75

mg

Filmcoated

tablet


2009-05-14

EE/H/011

6/Sykratan

irbesartan 150

mg

Filmcoated

tablet

Medis ehf. Reykjavikurvegi 76-78 220Hafnarfjordur Iceland

2009-05-14

EE/H/011

6/Sykratan

irbesartan 300

mg

Filmcoated

tablet


2009-05-14

EE/H/011

8/

Truttican New RMSEL/H/0131/001-

003/DC

irbesartan 150

mg

Filmcoated

tablet

Kleva S.A. 189, Parnithos Ave. 136 71 Acharnai- Attiki Greece

2009-05-14

EE/H/011

8/


003/DC

irbesartan 75

mg

Filmcoated

tablet


2009-05-14

EE/H/011

2/Irprestan

irbesartan 300

mg

Filmcoated

tablet


2009-05-14














EE/H/011

4/Irtucalan

irbesartan 75

mg

Filmcoated

tablet


2009-05-14

EE/H/011

4/Irtucalan

irbesartan 300

mg

Filmcoated

tablet


2009-05-14

EE/H/011

4/Irtucalan

irbesartan 150

mg

Filmcoated

tablet


2009-05-14

EE/H/011

2/Irprestan

irbesartan 150

mg

Filmcoated

tablet


2009-05-14

EE/H/011

8/


003/DC

irbesartan 300

mg

Filmcoated

tablet


2009-05-14

DE/H/1492/

MEFAM 300 mgFilmtabletten

irbesartan 300

mg

Filmcoated

tablet

ratiopharm, Germany 2009-05-27

DE/H/1492/


irbesartan 75

mg

Filmcoated

tablet


DE/H/1492/


irbesartan 150

mg

Filmcoated

tablet


DE/H/1491/

Irbesartan-CT 75mg Filmtabletten

irbesartan 75

mg

Filmcoated

tablet

AbZ-Pharma GmbH - Geschäftsanschrift -Graf-Arco-Str. 3 D-89079 Ulm

2009-05-27

DE/H/1491/


irbesartan 150

mg

Filmcoated

tablet


2009-05-27














DE/H/1491/


irbesartan 300

mg

Filmcoated

tablet


2009-05-27

ES/H/024

8/

IrbesartanFarmaprojects 75

mg

irbesartan 75

mg

Filmcoated

tablet

Farmaprojects S.A. Barcelona Spain 2009-07-29

NL/H/1526/

Irbesartan 75 A,filmomhulde

tabletten 75 mg

irbesartan 75

mg

Filmcoated

tablet

Apothecon BV Barneveld The Netherlands 2009-07-29

NL/H/1526/


tabletten 300 mg

irbesartan 300

mg

Filmcoated

tablet


NL/H/1527/

Irbesartan Wörwag150 mg

irbesartan 150

mg

Filmcoated

tablet

Wörwag Pharma GmbH & Co KG BöblingenGermany

2009-07-29

NL/H/1527/


irbesartan 300

mg

Filmcoated

tablet


2009-07-29

ES/H/024

8/

IrbesartanFarmaprojects 300mg, filmomhulde

tabletten

irbesartan 300

mg

Filmcoated

tablet


NL/H/1526/


tabletten 150 mg

irbesartan 150

mg

Filmcoated

tablet


ES/H/024

8/

IrbesartanFarmaprojects 75

mg

irbesartan 75

mg

Filmcoated

tablet


NL/H/1527/


irbesartan 75

mg

Filmcoated

tablet


2009-07-29














NL/H/1686/

Irbebon 75 mgirbesartan 75

mg

Filmcoated

tablet

Pharma Resources Dr. Schluttig GmbH Otto-Hahn Stra 46 633303 Dreieich Germany

2010-01-11

NL/H/1686/


mg

Filmcoated

tablet


2010-01-11

NL/H/1686/


mg

Filmcoated

tablet


2010-01-11

NL/H/1685/

Irbenidda 75 mgirbesartan 75

mg

Filmcoated

tablet


2010-01-11

NL/H/1685/


mg

Filmcoated

tablet


2010-01-11

NL/H/1685/


mg

Filmcoated

tablet


2010-01-11

EL/H/015

9/SEBESYN

irbesartan 150

mg

Filmcoated

tablet

Î¦Î‘Î¡ÎœÎ‘Î£Î¥Î� Î‘.Î•. 2010-02-21

EL/H/015

9/SEBESYN

irbesartan 300

mg

Filmcoated

tablet

Î¦Î‘Î¡ÎœÎ‘Î£Î¥Î� Î‘.Î•. 2010-02-21

EL/H/015

9/SEBESYN

irbesartan 75

mg

Filmcoated

tablet

Î¦Î‘Î¡ÎœÎ‘Î£Î¥Î� Î‘.Î•. 2010-02-21

IS/H/0141

/

Irbesartan InventFarma

irbesartan 75

mg

Filmcoated

tablet

Invent Farma S.L Avda. Barcelona 69, 08970,Sant Joan Despí (Barcelona) Spain

2010-02-21














IS/H/0141

/


irbesartan 150

mg

Filmcoated

tablet


2010-02-21

IS/H/0141

/


irbesartan 300

mg

Filmcoated

tablet


2010-02-21

PT/H/029

0/Alstin

irbesartan 150

mg

Filmcoated

tablet

Alfred E. Tiefenbacher GmbH & Co. KG 2010-03-23

PT/H/029

1/Fluppe

irbesartan 75

mg

Filmcoated

tablet


PT/H/029

1/Fluppe

irbesartan 150

mg

Filmcoated

tablet


PT/H/029

1/Fluppe

irbesartan 300

mg

Filmcoated

tablet


PT/H/029

2/

IrbesartanTiefenbacher

irbesartan 75

mg

Filmcoated

tablet


PT/H/029

2/


irbesartan 150

mg

Filmcoated

tablet


PT/H/029

0/Alstin

irbesartan 75

mg

Filmcoated

tablet


PT/H/029

3/

Irbesartan+pharma

irbesartan 75

mg

Filmcoated

tablet















PT/H/028

9/Elbin

irbesartan 75

mg

Filmcoated

tablet


PT/H/028

9/Elbin

irbesartan 150

mg

Filmcoated

tablet


PT/H/029

0/Alstin

irbesartan 300

mg

Filmcoated

tablet


PT/H/029

2/


irbesartan 300

mg

Filmcoated

tablet


PT/H/028

9/Elbin

irbesartan 300

mg

Filmcoated

tablet


PT/H/029

3/

Irbesartan+pharma

irbesartan 150

mg

Filmcoated

tablet


PT/H/029

3/

Irbesartan+pharma

irbesartan 300

mg

Filmcoated

tablet


DE/H/3845/

IrbesartanHeumann 300 mg

Tabletten

irbesartan 300

mg

Tablet

Heumann Pharma GmbH & Co. Generica KGSüdwestpark 50 90449 Nürnberg Germany

2010-04-02

NL/H/1626/

Licolin 300 mgTablet

irbesartan 300

mg

Tablet

Laboratorios Liconsa, S.A. Gran Via Carlos III,98, 7th 08028 Barcelona Spain

2010-04-02

DE/H/3845/


Tabletten

irbesartan 75

mg

Tablet


2010-04-02

NL/H/1623/

Agepin 150 mgTablet

irbesartan 150

mg

Tablet


2010-04-02

DE/H/3845/


Tabletten

irbesartan 150

mg

Tablet


2010-04-02
















NL/H/1628/

Ardinel 75 mgTablet

irbesartan 75

mg

Tablet


2010-04-02

NL/H/1628/

Ardinel 150 mgTablet

irbesartan 150

mg

Tablet


2010-04-02

NL/H/1628/

Ardinel 300 mgTablet

irbesartan 300

mg

Tablet


2010-04-02

NL/H/1623/

Agepin 300 mgTablet

irbesartan 300

mg

Tablet


2010-04-02

NL/H/1623/

Agepin 75 mgTablet

irbesartan 75

mg

Tablet


2010-04-02

NL/H/1626/

Licolin 75 mgTablet

irbesartan 75

mg

Tablet


2010-04-02

NL/H/1626/

Licolin 150 mgTablet

irbesartan 150

mg

Tablet


2010-04-02

NL/H/1760/

Abesart 150 mgirbesartan 150

mg

Filmcoated

tablet

Genepharm Europe Trading Ltd. El GrecoHouse, 1066 Nicosia Cyprus

2010-06-03

NL/H/1760/

Abesart 300 mgirbesartan 300

mg

Filmcoated

tablet


2010-06-03

NL/H/1759/

Irbertan 75 mgirbesartan 75

mg

Filmcoated

tablet


2010-06-03

NL/H/1759/


mg

Filmcoated

tablet


2010-06-03

NL/H/1759/


mg

Filmcoated

tablet


2010-06-03

FR/H/042

8/

Irbesartan 75 mgfilm-coated tablet

irbesartan 75

mg

Filmcoated

tablet

Medipha Sante SN France 2010-07-21

















FR/H/042

8/


irbesartan 300

mg

Filmcoated

tablet


FR/H/042

8/


irbesartan 150

mg

Filmcoated

tablet


PT/H/034

0/

IrbesartanPharmakern

irbesartan 150

mg

Filmcoated

tablet

Pharmakern Portugal - ProdutosFarmacêuticos, Sociedade Unipessoal, Lda.

Edifício Atlas II, Av. José Gomes Ferreira, N.º 11- 3

2010-10-09

PT/H/034

0/


irbesartan 300

mg

Filmcoated

tablet



2010-10-09

PT/H/034

0/


irbesartan 75

mg

Filmcoated

tablet



2010-10-09

NL/H/2022/

Ybersigal 150 mgirbesartan 150

mg

Filmcoated

tablet

Galex d.d. Galex d.d. TiÅ¡inska ulica 29g 9000Murska Sobota Slovenia

2010-11-25

NL/H/2022/

Ybersigal 300 mgirbesartan 300

mg

Filmcoated

tablet

Galex d.d. Galex d.d. TiÅ¡inska ulica 29g 9000Murska Sobota Slovenia

2010-11-25

NL/H/1956/

Irbesartan ApotexEurope B.V. 150

mg

irbesartan 150

mg

Filmcoated

tablet

Apotex Europe BV Darwinweg 20 2333 CRLeiden The Netherlands

2010-12-06

NL/H/1956/

Irbesartan ApotexEurope B.V. 75 mg

irbesartan 75

mg

Filmcoated

tablet


2010-12-06

NL/H/1956/

Irbesartan ApotexEurope B.V. 300

mg

irbesartan 300

mg

Filmcoated

tablet


2010-12-06














UK/H/2638/

Irbesartan 300 mgfilm-coated tablets

irbesartan 300

mg

Filmcoated

tablet

DR REDDY'S LABORATORIES (UK) LIMITED 2011-03-11

UK/H/2638/


irbesartan 75

mg

Filmcoated

tablet


UK/H/2638/


irbesartan 150

mg

Filmcoated

tablet


PT/H/029

9/

IrbesartanTecnimede

irbesartan 75

mg

Filmcoated

tablet

Tecnimede, S.A Rua da Tapada Grande, 22710-089 Sintra Portugal

2011-04-06

PT/H/029

9/

IrbesartanTecnimede

irbesartan 150

mg

Filmcoated

tablet


2011-04-06

PT/H/029

9/

IrbesartanTecnimede

irbesartan 300

mg

Filmcoated

tablet


2011-04-06

PT/H/035

5/Irbesartan Amneal

irbesartan 300

mg

Tablet

Amneal Pharma Europe Limited 2011-04-20

PT/H/035

5/Irbesartan Amneal

irbesartan 150

mg

Tablet


PT/H/035

5/Irbesartan Amneal

irbesartan 75

mg

Tablet


PT/H/043

8/Irbesartan Welding

irbesartan 150

mg

Filmcoated

tablet

Welding GmbH & Co. KG Esplanade 39 20354Hamburg Germany

2011-06-29

PT/H/043


irbesartan 75

mg

Filmcoated

tablet


2011-06-29















PT/H/043


irbesartan 300

mg

Filmcoated

tablet


2011-06-29

UK/H/1963/

Irbesartan 300mgFilm-coated

Tablets

irbesartan 300

mg

Filmcoated

tablet

USV EUROPE LIMITED 2011-07-06

UK/H/1963/

Irbesartan 150 mgFilm-coated

Tablets

irbesartan 150

mg

Filmcoated

tablet


UK/H/1963/

Irbesartan 75 mgFilm-coated

Tablets

irbesartan 75

mg

Filmcoated

tablet


DE/H/2735/

Irbesartan Helm 75mg

irbesartan 75

mg

Filmcoated

tablet

Helm AG Nordkanalstrasse 28 20097 HamburgGermany

2011-07-13

DE/H/2735/

Irbesartan Helm300 mg

irbesartan 300

mg

Filmcoated

tablet


2011-07-13

DE/H/2735/

Irbesartan Helm150 mg

irbesartan 150

mg

Filmcoated

tablet


2011-07-13

UK/H/5918/

Irbesartan Arcana150 mg Tabletten

irbesartan 150

mg

Tablet

Arcana Arzneimittel GmbH, HütteldorferStraße 299, 1140 Wien, Österreich

2011-08-01

UK/H/5918/


irbesartan 300

mg

Tablet


2011-08-01

UK/H/5918/


irbesartan 75

mg

Tablet


2011-08-01

NL/H/2066/

Irbesartan Torrent300 mg

filmomhuldetabletten

irbesartan 300

mg

Filmcoated

tablet

Heumann Pharma GmbH & Co. Generika KGSüdwestpark 50 90449 Nürnberg Germany

2011-10-13















NL/H/2066/



irbesartan 75

mg

Filmcoated

tablet


2011-10-13

NL/H/2066/



irbesartan 150

mg

Filmcoated

tablet


2011-10-13

UK/H/3094/

Irbesartan 'Arrow'300 mg Tablets

irbesartan 300

mg

Filmcoated

tablet

Arrow Generics Ltd. Robert [email protected]

2012-03-21

UK/H/3094/


irbesartan 150

mg

Filmcoated

tablet

Arrow Generics Limited Robert [email protected]

2012-03-21

UK/H/3094/


irbesartan 75

mg

Filmcoated

tablet

Arrow Generics Ltd. Robert [email protected]

2012-03-21

EL/H/012

5/

IRBESARTAN/GENEPHARM

irbesartan 75

mg

Filmcoated

tablet

GENEPHARM A.E. 2012-04-02

EL/H/012

5/


irbesartan 150

mg

Filmcoated

tablet


EL/H/012

5/


irbesartan 300

mg

Filmcoated

tablet


UK/H/3569/


irbesartan 75

mg

Filmcoated

tablet

MACLEODS PHARMA UK LTD. RakeshChaurasia

[email protected]

UK/H/3569/


irbesartan 150

mg

Filmcoated

tablet

Macleods Pharma UK Ltd Rakesh [email protected]

2012-04-18














UK/H/3569/


irbesartan 300

mg

Filmcoated

tablet

Macleods Pharma UK Ltd Rakesh [email protected]

2012-04-18

PT/H/045

2/Irbesartan Germed

irbesartan 75

mg

Filmcoated

tablet

Germed Farmacêutica, Lda. PRT 2012-04-30

PT/H/045

2/Irbesartan Germed

irbesartan 150

mg

Filmcoated

tablet


PT/H/045

2/Irbesartan Germed

irbesartan 75

mg

Filmcoated

tablet


DE/H/2961/

Irbesartan Hennig300 mg

Filmtabletten

irbesartan 300

mg

Filmcoated

tablet

Hennig Arzneimittel GmbH & Co.KG Liebigstr.1 65439 Flörsheim Germany

2012-05-09

DE/H/2961/


Filmtabletten

irbesartan 150

mg

Filmcoated

tablet


2012-05-09

DE/H/2961/


Filmtabletten

irbesartan 75

mg

Filmcoated

tablet


2012-05-09

DE/H/3104/

Generitan 300 mgFilmtabletten

irbesartan 300

mg

Filmcoated

tablet

G.L.-Pharma GmbH Schlossplatz 1 A-8502LANNACH Austria

2012-05-09

DE/H/3104/


irbesartan 150

mg

Filmcoated

tablet


2012-05-09

DE/H/3104/


irbesartan 75

mg

Filmcoated

tablet


2012-05-09














UK/H/4262/

Irbesartan 300 mgFilm-coated tablets

irbesartan 300

mg

Filmcoated

tablet

FirstGenerixInternational GmbH Deinhardplatz3, 56068 Koblenz Germany

2012-05-11

UK/H/4262/


irbesartan 150

mg

Filmcoated

tablet


2012-05-11

UK/H/4262/


irbesartan 75

mg

Filmcoated

tablet


2012-05-11

DE/H/3279/

Irbesartan-Hormosan 300 mg

Filmtabletten

irbesartan 300

mg

Filmcoated

tablet

Hormosan Pharma Gesellschaft mitbeschränkter Haftung Wilhelmshöher Str. 106

D-60389 Frankfurt am Main Germany2012-06-14

DE/H/3279/


Filmtabletten

irbesartan 150

mg

Filmcoated

tablet



DE/H/3279/


Filmtabletten

irbesartan 75

mg

Filmcoated

tablet



NL/H/2610/

IrbesartanAurobindo 150 mg,

tabletten

irbesartan 150

mg

Tablet

Aurobindo Pharma B.V. Molenvliet 103,3335LH Zwijndrecht The Netherlands

2012-06-24

NL/H/2610/

IrbesartanAurobindo 300 mg,

tabletten

irbesartan 300

mg

Tablet

Aurobindo Pharma B.V. Molenvliet 103,3335LH Zwijndrecht The Netherlands

2012-06-24

PT/H/062

9/

IrbesartanAurobindo

irbesartan 75

mg

Tablet

Aurobindo Pharma (Portugal), Unipessoal Lda 2012-07-12

PT/H/062

9/

IrbesartanAurobindo

irbesartan 150

mg

Tablet


PT/H/062

9/

IrbesartanAurobindo

irbesartan 300

mg

Tablet


HU/H/0333/

IRPRESTANirbesartan 300

mg

Filmcoated

tablet


2012-07-31
















HU/H/0333/


mg

Filmcoated

tablet


2012-07-31

HU/H/0333/


mg

Filmcoated

tablet


2012-07-31

PT/H/071

3/Irbesartan Bluefish

irbesartan 75

mg

Filmcoated

tablet

Bluefish Pharmaceuticals AB Torsgatan 11, 8tr111 23 Stockholm Suécia

2012-09-04

PT/H/071


irbesartan 150

mg

Filmcoated

tablet


2012-09-04

PT/H/071


irbesartan 300

mg

Filmcoated

tablet


2012-09-04

PT/H/071

4/Irbeblue

irbesartan 75

mg

Filmcoated

tablet

Bluefish Pharmaceuticals AB 2012-09-04

PT/H/071

4/Irbeblue

irbesartan 150

mg

Filmcoated

tablet


PT/H/071

4/Irbeblue

irbesartan 300

mg

Filmcoated

tablet


PT/H/071

5/Irbesartan Hetero

irbesartan 75

mg

Filmcoated

tablet

Hetero Europe, SL Ferreries, 11 08230Matadepera (Barcelona) Espanha

2012-09-04

PT/H/071

5/Irbesartan Hetero

irbesartan 150

mg

Filmcoated

tablet


2012-09-04














PT/H/071

5/Irbesartan Hetero

irbesartan 300

mg

Filmcoated

tablet


2012-09-04

NL/H/2453/

Irbesartan Jubilant75 mg

irbesartan 75

mg

Filmcoated

tablet

Jubilant Pharmaceuticals nv Axxes BusinessPark Guldensporenpark 22 - Block C 9820

Merelbeke Belgium2012-09-09

NL/H/2453/


irbesartan 150

mg

Filmcoated

tablet



NL/H/2453/


irbesartan 300

mg

Filmcoated

tablet



EL/H/016

0/Gemot 75 mg

irbesartan 75

mg

Filmcoated

tablet

Terix Labs Ltd. 6 Agias Elenis str, Agias ElenisBuilding, office 43, 1060 Nicosia Cyprus

2012-09-09

EL/H/016

0/Gemot 150 mg

irbesartan 150

mg

Filmcoated

tablet


2012-09-09

EL/H/016

0/Gemot 300 mg

irbesartan 300

mg

Filmcoated

tablet


2012-09-09

NL/H/2568/

IrbesartanUnichem 150mg

film coated tablets

irbesartan 150

mg

Filmcoated

tablet

Unichem Laboratories Limited Studio 8b, ArdGaoithe Commercial Centre, Ard Goaithe

Business Park, Cashel Road, Clonmel, Co. Tip2012-12-18

NL/H/2568/

IrbesartanUnichem 300mg

film coated tablets

irbesartan 300

mg

Filmcoated

tablet

Unichem Laboratories Limited Studio 8b, ArdGaoithe Commercial Centre, Ard Goaithe

Business Park, Cashel Road, Clonmel, Co. Tip2012-12-18

PT/H/078

3/Irbesartan Vocate

irbesartan 150

mg

Tablet

Vocate Pharmaceuticals, S.A. 2013-05-14

PT/H/078

3/Irbesartan Vocate

irbesartan 300

mg

Tablet

Vocate Pharmaceuticals, S.A. 2013-05-14















EL/H/013

1/BESARTAN

irbesartan 75MG

Filmcoated

tablet

BENNETT PHARMACEUTICALS SA Agia Kyriaki20, 145 61, Kifissia

2013-11-26

EL/H/013

1/BESARTAN

irbesartan 150

MG

Filmcoated

tablet


2013-11-26

EL/H/013

1/BESARTAN

irbesartan 300

MG

Filmcoated

tablet


2013-11-26

PT/H/121

9/Irbesartan Brown

irbesartan 75

mg

Filmcoated

tablet

Brown & Burk UK Ltd 2015-05-06

PT/H/121

9/Irbesartan Brown

irbesartan 150

mg

Filmcoated

tablet


PT/H/121

9/Irbesartan Brown

irbesartan 300

mg

Filmcoated

tablet


IT/H/0377

/Sykratan

irbesartan 150

mg

Filmcoated

tablet


2015-05-12

IT/H/0377

/Sykratan

irbesartan 300

mg

Filmcoated

tablet


2015-05-12

HU/H/0412/

IRBESARTAN Elpen75 mg film-coated

tablet

irbesartan 75

mg

Film-

coated

tablet

Elpen Pharmaceutical Co. Inc. (Greece) 2016-02-12

HU/H/0412/

IRBESARTAN Elpen150 mg film-coated tablet

irbesartan 150

mg

Film-

coated

tablet















HU/H/0412/

IRBESARTAN Elpen300 mg film-coated tablet

irbesartan 300

mg

Film-

coated

tablet


DE/H/4253/

Irbesartan Mylan300 mg

Filmtabletten

irbesartan 300

mg

Filmcoated

tablet

Mylan dura GmbH Wittichstr. 6 D-64295Darmstadt Germany

2016-03-01

DE/H/4253/


Filmtabletten

irbesartan 150

mg

Filmcoated

tablet


2016-03-01

DE/H/4253/


Filmtabletten

irbesartan 75

mg

Filmcoated

tablet


2016-03-01

DE/H/4001/

Irbesartan HECPharm 300 mgFilmtabletten

irbesartan 300

mg

Filmcoated

tablet

HEC Pharm GmbH Gabriele-Tergit-Promenade17 D-10963 Berlin Germany

2016-03-24

DE/H/4001/


irbesartan 150

mg

Filmcoated

tablet


2016-03-24

DE/H/4001/


irbesartan 75

mg

Filmcoated

tablet


2016-03-24

PT/H/154

0/Irbesartan Ritisca

irbesartan 75

mg

Tablet

Aurovitas, Unipessoal, Lda 2016-09-21

PT/H/154


irbesartan 150

mg

Tablet


PT/H/154


irbesartan 300

mg

Tablet


商标名活性成份申请类型申请公司批准日期

日本上市情况(19条)













Irbetan Tablets 50 mgIrbesart

anApprov

alShionogi & Co., Ltd.

2008-04-16

Irbetan Tablets 100 mgIrbesart

anApprov

alShionogi & Co., Ltd.

2008-04-16

Avapro Tablets 50 mgIrbesart

anApprov

alDainippon Sumitomo Pharma Co., Ltd.

2008-04-16

Avapro Tablets 100 mgIrbesart

anApprov

alDainippon Sumitomo Pharma Co., Ltd.

2008-04-16

イルトラ配合錠LD／イルトラ配合錠HDIrbesart

an提携　SANOFI 製造販売元／塩野義製薬

株式会社1986/11

イルベタン錠50mg／イルベタン錠100mg／イルベタン錠200mg

Irbesartan

提携　SANOFI 製造販売元／塩野義製薬株式会社

1986/10

イルベサルタン錠50mg「オーハラ」／イルベサルタン錠100mg「オーハラ」／

イルベサルタン錠200mg「オーハラ」

Irbesartan

製造販売元／大原薬品工業株式会社 1999/09

イルベサルタン錠50mg「オーハラ」／イルベサルタン錠100mg「オーハラ」／

イルベサルタン錠200mg「オーハラ」

Irbesartan

販売元／日本ジェネリック株式会社製造販売元／大原薬品工業株式会社

1982/02

イルベサルタン錠50mg「共創未来」／イルベサルタン錠100mg「共創未来」／

イルベサルタン錠200mg「共創未来」

Irbesartan

製造販売元／共創未来ファーマ株式会社 2008/11

イルベサルタン錠50mg「ケミファ」／イルベサルタン錠100mg「ケミファ」／

イルベサルタン錠200mg「ケミファ」

Irbesartan

製造販売元／日本ケミファ株式会社 2008/11

イルベサルタン錠50mg「サワイ」／イルベサルタン錠100mg「サワイ」／イル

ベサルタン錠200mg「サワイ」

Irbesartan

製造販売元／沢井製薬株式会社 1986/03

イルベサルタン錠50mg「トーワ」／イルベサルタン錠100mg「トーワ」／イル

ベサルタン錠200mg「トーワ」

Irbesartan

製造販売元／東和薬品株式会社 1981/09

イルベサルタン錠50mg「日医工」／イルベサルタン錠100mg「日医工」／イル

ベサルタン錠200mg「日医工」

Irbesartan

製造販売元／日医工株式会社

イルベサルタン錠50mg「ニプロ」／イルベサルタン錠100mg「ニプロ」／イル

ベサルタン錠200mg「ニプロ」

Irbesartan

製造販売／ニプロ株式会社 2010/04

イルベサルタン錠50mg「DSPB」／イルベサルタン錠100mg「DSPB」／イルベ

サルタン錠200mg「DSPB」

Irbesartan

製造販売元／ＤＳファーマバイオメディカル株式会社販売元／大日本住友製薬株式会社プロモーション提携／ＤＳファー

マプロモ株式会社提携／SANOFI

1994/02

イルベサルタン錠50mg「EE」／イルベサルタン錠100mg「EE」／イルベサル

タン錠200mg「EE」

Irbesartan

製造販売元／エルメッドエーザイ株式会社販売提携／エーザイ株式会社

1986/10

イルベサルタン錠50mg「KN」／イルベサルタン錠100mg「KN」／イルベサル

タン錠200mg「KN」

Irbesartan

製造販売元／小林化工株式会社 1986/10

http://db.yaozh.com/jpchu/9003.html






イルベサルタンOD錠50mg「トーワ」／イルベサルタンOD錠100mg「トーワ」

／イルベサルタンOD錠200mg「トーワ」

Irbesartan

製造販売元／東和薬品株式会社 1986/10

アバプロ錠50mg／アバプロ錠100mg／アバプロ錠200mg

Irbesartan

製造販売元／大日本住友製薬株式会社提携／SANOFI

2010/01

国家名称上市公司商标名活性成分适应症状态

Arg Sandoz Adana Irbesartan 高血压

Arg. Sanofi Synthelabo Aprovel Irbesartan 糖尿病性肾病;高血压

Belg. Sanofi-Aventis Aprovel Irbesartan 糖尿病性肾病;高血压

Braz. Sanofi- Aventis Aprovel Irbesartan 糖尿病性肾病;高血压

Chile Sanofi-Aventis Aprovel Irbesartan 糖尿病性肾病;高血压

Cz. Sanofi-Aventis Aprovel Irbesartan 糖尿病性肾病;高血压

Denm. Sanofi Aprovel Irbesartan 糖尿病性肾病;高血压

Fin. BMS Aprovel Irbesartan 糖尿病性肾病;高血压

Fr. BMS Aprovel Irbesartan 糖尿病性肾病;高血压

Ger. Sanofi Synthelabo Aprovel Irbesartan 糖尿病性肾病;高血压

Gr. Sanofi-Aventis Aprovel Irbesartan 糖尿病性肾病;高血压

Hong Kong Sanofi- Aventis Aprovel Irbesartan 糖尿病性肾病;高血压

Hung. BMS Aprovel Irbesartan 糖尿病性肾病;高血压

Hung. Sanofi-Aventis Aprovel Irbesartan 糖尿病性肾病;高血压

Indon. Sanofi-Aventis Aprovel Irbesartan 糖尿病性肾病;高血压

Irl. BMS Aprovel Irbesartan 糖尿病性肾病;高血压

Irl. Sanofi-Aventis Aprovel Irbesartan 糖尿病性肾病;高血压

Ital. Sanofi-Aventis Aprovel Irbesartan 糖尿病性肾病;高血压

Malaysia Sanofi-Aventis Aprovel Irbesartan 糖尿病性肾病;高血压

Mex. Sanofi Synthelabo Aprovel Irbesartan 糖尿病性肾病;高血压

Neth. BMS Aprovel Irbesartan 糖尿病性肾病;高血压

Neth. Sanofi Aprovel Irbesartan 糖尿病性肾病;高血压

Norw. Sanofi BMS Aprovel Irbesartan 糖尿病性肾病;高血压

Philipp. Sanofi Synthelabo Aprovel Irbesartan 糖尿病性肾病;高血压

Pol. BMS Aprovel Irbesartan 糖尿病性肾病;高血压

Pol. Sanofi-Aventis Aprovel Irbesartan 糖尿病性肾病;高血压

Port. BMS Aprovel Irbesartan 糖尿病性肾病;高血压

主要上市国家/地区(64条) 隐藏




Port. Sanofi Synthelabo Aprovel Irbesartan 糖尿病性肾病;高血压

Rus. Sanofi Winthrop Aprovel Irbesartan 糖尿病性肾病;高血压

S.Afr. Sanofi Synthelabo Aprovel Irbesartan 糖尿病性肾病;高血压

Singapore Sanofi-Aventis Aprovel Irbesartan 糖尿病性肾病;高血压

Spain Sanofi-Aventis Aprovel Irbesartan 糖尿病性肾病;高血压

Swed. BMS Aprovel Irbesartan 糖尿病性肾病;高血压

Swed. Sanofi Synthelabo Aprovel Irbesartan 糖尿病性肾病;高血压

Switz. BMS Aprovel Irbesartan 糖尿病性肾病;高血压

Switz. Sanofi Aprovel Irbesartan 糖尿病性肾病;高血压

Thai. Sanofi Synthelabo Aprovel Irbesartan 糖尿病性肾病;高血压

UK BMS Aprovel Irbesartan 糖尿病性肾病;高血压

UK Sanofi Synthelabo Aprovel Irbesartan 糖尿病性肾病;高血压

Venez Sanofi-Aventis Aprovel Irbesartan 糖尿病性肾病;高血压

Arg. BMS Avapro Irbesartan 糖尿病性肾病;高血压

Austral. BMS Avapro Irbesartan 糖尿病性肾病;高血压

Braz. BMS Avapro Irbesartan 糖尿病性肾病;高血压

Canad. BMS Avapro Irbesartan 糖尿病性肾病;高血压

Canad. Sanofi Synthelabo Avapro Irbesartan 糖尿病性肾病;高血压

Mex. BMS Avapro Irbesartan 糖尿病性肾病;高血压

USA BMS Avapro Irbesartan 糖尿病性肾病;高血压

USA Sanofi Winthrop Avapro Irbesartan 糖尿病性肾病;高血压

Indon Kalbe Fristens Irbesartan 高血压

Israel* BMS Irban Irbesartan 糖尿病性肾病;高血压可能已退市

Indon Fahrenheit Iretensa Irbesartan 高血压

India Sun Irovel Irbesartan 高血压

Indon Novell Irvell Irbesartan 高血压

Austral. Sanofi-Aventis Karvea Irbesartan 糖尿病性肾病;高血压

Cz. BMS Karvea Irbesartan 糖尿病性肾病;高血压

Ger. BMS Karvea Irbesartan 糖尿病性肾病;高血压

Gr. BMS Karvea Irbesartan 糖尿病性肾病;高血压

Ital. BMS Karvea Irbesartan 糖尿病性肾病;高血压

NZ Sanofi-Aventis Karvea Irbesartan 糖尿病性肾病;高血压

Neth. BMS Karvea Irbesartan 糖尿病性肾病;高血压

Port. BMS Karvea Irbesartan 糖尿病性肾病;高血压




Spain BMS Karvea Irbesartan 糖尿病性肾病;高血压

Turk Sanofi Synthelabo Karvea Irbesartan 糖尿病性肾病;高血压

India Nicholas Piramal Xarb Irbesartan 糖尿病性肾病;高血压

药品名称批准文号药品规格生产厂商国产厂家数量是否医保

厄贝沙坦片国药准字

H2000054575mg 安徽环球药业股份有限公司 9 乙


H2000051075mg 深圳市海滨制药有限公司 9 乙

厄贝沙坦国药准字

H20000509----

珠海保税区丽珠合成制药有限公司

11


H200005110.15g 深圳市海滨制药有限公司 9 乙


H2000053775mg 南京长澳制药有限公司 9 乙


H200005130.15g 江苏恒瑞医药股份有限公司 9 乙


H20000512---- 江苏盛迪医药有限公司 11

厄贝沙坦胶囊

国药准字H20000546

75mg 上海信谊天平药业有限公司 5 乙


H2000051675mg 海正辉瑞制药有限公司 9 乙


H20000505---- 浙江华海药业股份有限公司 11


H20000514---- 浙江海正药业股份有限公司 11

厄贝沙坦胶囊

国药准字H20052155

75mg 浙江弘盛药业有限公司 5 乙


H20000507----

扬子江药业集团江苏海慈生物药业有限公司

11

厄贝沙坦胶囊

国药准字H20073595

75mg扬子江药业集团广州海瑞药业有

限公司5 乙


H2003001675mg 浙江华海药业股份有限公司 9 乙

厄贝沙坦胶囊

国药准字H20000540

150mg 珠海润都制药股份有限公司 5 乙

厄贝沙坦胶囊

国药准字H20093583

75mg 珠海润都制药股份有限公司 5 乙

中国上市情况(44条) 隐藏

https://db.yaozh.com/pijian/99601.html





















H2010016475mg

扬子江药业集团北京海燕药业有限公司

9 乙


H20103681---- 浙江天宇药业股份有限公司 11

厄贝沙坦分散片

国药准字H20110024

0.15g 潍坊中狮制药有限公司 3 乙


H20113190---- 浙江金立源药业有限公司 11


H20113340---- 珠海润都制药股份有限公司 11


H20123107－－－－浙江普洛家园药业有限公司 11


国药准字H20123406

0.075g 潍坊中狮制药有限公司 3 乙


H200409970.3g 海正辉瑞制药有限公司 9 乙


H200409960.15g 海正辉瑞制药有限公司 9 乙


H200404940.15g 赛诺菲(杭州)制药有限公司 9 乙


H200539120.15g 修正药业集团股份有限公司 9 乙


国药准字H20060794

75mg 石家庄以岭药业股份有限公司 3 乙

厄贝沙坦胶囊

国药准字H20010530

0.075g 哈药集团制药六厂 5 乙


国药准字H20100170

0.15g 华润双鹤利民药业(济南)有限公司 3 乙


H20173036---- 威特(湖南)药业有限公司 11


H20000538---- 修正药业集团柳河制药有限公司 11

厄贝沙坦片 J20130049 0.15g Sanofi Winthrop Industrie 法国进口乙

厄贝沙坦片 J20130056 0.3g Sanofi Winthrop Industrie 法国进口乙

厄贝沙坦颗粒

H20150460每1g颗粒含厄贝沙坦

600mgSANOFI WINTHROP

INDUSTRIE法国进口

厄贝沙坦片 H20171181 75mg Sanofi Winthrop Industrie 法国进口乙

厄贝沙坦片 H20171183 0.15g Sanofi Winthrop Industrie 法国进口乙



厄贝沙坦片 H20171180 75mg Sanofi Winthrop Industrie 法国进口乙


















https://db.yaozh.com/jinkou/223.html














受理号码药品名称申请类型注册分类承办日期企业名称办理状态状态开始日期审批结论

CXS01005厄贝沙坦

胶囊新药 2

2001-01-31

成都市高新区药工医药生物技术研究所哈药

集团制药六厂

已发批件 2001-09-12 批准生产

H20020266伊贝沙坦

片进口

2002-10-29

法国赛诺菲圣德拉堡集团中国分公司北京办事

处

审批完毕 2003-07-08 批准

J0300182伊贝沙坦

片补充申请

2003-03-11

杭州赛诺菲圣德拉堡民生制药有限公

司

已发批件 2003-08-08 批准


片补充申请

2003-03-11


司

审批完毕－待制证

2003-08-04 批准


片补充申请

2003-03-11


司

审批完毕－待制证

2003-08-04 批准

X0304126厄贝沙坦

片新药

2003-08-09


司

已发批件 2004-04-16 批准生产

X0306598厄贝沙坦口腔崩解

片新药 5

2003-12-17

武汉迪生生物制剂工程有限

公司

已发批件 2004-07-19 批准临床


片补充申请

2004-03-03

浙江海正药业股份有限公司

已发批件 2004-07-29 批准补充


片补充申请

2004-03-03



中国注册申报情况(143条) 隐藏



https://db.yaozh.com/zhuce/ZpmVaQ==.html

https://db.yaozh.com/zhuce/ZpSYaGc=.html

https://db.yaozh.com/zhuce/ZpaSaGE=.html

https://db.yaozh.com/zhuce/ZpaSaGI=.html

https://db.yaozh.com/zhuce/ZpaSaGo=.html

https://db.yaozh.com/zhuce/ZpiVaWg=.html

https://db.yaozh.com/zhuce/Zp2RaWM=.html

https://db.yaozh.com/zhuce/Z5WWa2Q=.html

https://db.yaozh.com/zhuce/Z5WWa2U=.html





片补充申请

2004-03-03




胶囊补充申请

2004-03-08




分散片新药 5

2004-04-14

石家庄以岭药业股份有限公

司



片补充申请

2004-07-20


司


X0405257 厄贝沙坦补充申请2004-09-

16

浙江华海药业股份有限公司

已发件 2005-02-04 批准补充


片补充申请

2004-09-20


已发件 2005-02-04 批准补充


胶囊补充申请

2004-11-18

珠海润都制药有限

公司已发件 2005-03-24 批准临床

JYHB0500084

厄贝沙坦片

补充申请2005-03-

28

法国赛诺菲圣德拉堡集团中国分公司

制证完毕－待发批件

2006-04-20 批准补充

JYHB0500085

厄贝沙坦片

补充申请2005-03-

28在审批 2006-11-02 批准补充

JYHB0500086

厄贝沙坦片

补充申请2005-03-

28



2006-04-20 批准补充

JYHB0500081

厄贝沙坦片

补充申请2005-03-

28



2006-04-20 批准补充

JYHB0500083

厄贝沙坦片

补充申请2005-03-

28在审批 2006-11-02 批准补充

JYHB0500082

厄贝沙坦片

补充申请2005-03-

28在审批 2006-11-02 批准补充

CXHB0500945

厄贝沙坦补充申请2005-05-

19

南京长澳制药有限

公司已发批件 2005-08-25 批准补充

CXHL0501189


新药 52005-06-

10

济南利民制药有限责任公司


https://db.yaozh.com/zhuce/Z5WWbGc=.html

https://db.yaozh.com/zhuce/Z5WXbWI=.html

https://db.yaozh.com/zhuce/Z5eTb2I=.html

https://db.yaozh.com/zhuce/Z5uWa2o=.html

https://db.yaozh.com/zhuce/aJWRb2Q=.html

https://db.yaozh.com/zhuce/aJWVamQ=.html

https://db.yaozh.com/zhuce/aJmYaGI=.html

https://db.yaozh.com/zhuce/aZiZbGM=.html

https://db.yaozh.com/zhuce/aZiZbGQ=.html

https://db.yaozh.com/zhuce/aZiZbGU=.html

https://db.yaozh.com/zhuce/aZiZbGg=.html

https://db.yaozh.com/zhuce/aZiZbGk=.html

https://db.yaozh.com/zhuce/aZiZbGo=.html

https://db.yaozh.com/zhuce/aZyVZ2g=.html

https://db.yaozh.com/zhuce/apSUa2c=.html




CXHS0501216


新药 52005-08-

09


司

已发件 2006-06-02 批准生产

JXHB0690002

伊贝沙坦片

补充申请2006-01-

24


司

制证完毕－已发批件

2007-03-20 批准补充

JXHB0690003

伊贝沙坦片

补充申请2006-01-

24


司


2007-03-20 批准补充

JXHB0690004

伊贝沙坦片

补充申请2006-01-

24


司


2007-03-20 批准补充

CXHS0503236

厄贝沙坦口腔崩解

片新药 5

2006-02-07

武汉维奥制药有限

公司


2008-11-12 不批准

CXHL0600172


新药 52006-04-

06

潍坊中狮制药有限

公司已发批件 2008-01-10 批准临床

CYHB0600983

厄贝沙坦胶囊

补充申请2006-08-

01


公司


2007-03-07 批准临床

CXHB0601028

厄贝沙坦片

补充申请2006-09-

22

扬子江药业集团江苏制药股份有限公

司


2007-01-11 批准临床

CXHB0601274


补充申请2006-11-

10


司


CXHB0790010

厄贝沙坦片

补充申请2007-07-

16

扬子江药业集团江苏制药股份有限公

司


2008-06-20 批准补充

CYHB0701929

厄贝沙坦片

补充申请2008-02-

21

修正药业集团股份有限公司


2008-08-07 不批准

CYHB0890011

厄贝沙坦胶囊

补充申请2008-04-

11


公司


2009-03-09 批准补充

JYHB0800375

厄贝沙坦片

补充申请2008-06-

06无


2009-01-07 批准补充

https://db.yaozh.com/zhuce/apmUaGY=.html

https://db.yaozh.com/zhuce/a52WamY=.html

https://db.yaozh.com/zhuce/a52Wamc=.html

https://db.yaozh.com/zhuce/a52Wamg=.html

https://db.yaozh.com/zhuce/bJSTZ2I=.html

https://db.yaozh.com/zhuce/bJqZbWY=.html

https://db.yaozh.com/zhuce/bZmScGY=.html

https://db.yaozh.com/zhuce/bZuRa2Q=.html

https://db.yaozh.com/zhuce/bZySbmU=.html

https://db.yaozh.com/zhuce/bpaaamY=.html

https://db.yaozh.com/zhuce/bpuWbWY=.html

https://db.yaozh.com/zhuce/bpyWaWg=.html

https://db.yaozh.com/zhuce/bp2Xamg=.html




JYHB0800377

厄贝沙坦片

补充申请2008-06-

06无


2009-01-07 批准补充

JYHB0800374

厄贝沙坦片

补充申请2008-06-

06无


2009-01-07 批准补充

CXHS0800106


新药 52008-08-

25

济南利民制药有限责任公司


2010-11-23 批准生产

CYHB0811666


08



2009-06-25 批准补充

CYHB0810287

厄贝沙坦片

补充申请2009-02-

04



2009-07-29 批准临床

CXHL0800492

厄贝沙坦胃内滞留型缓释片

新药 52009-02-

04

广州贝氏药业有限

公司


2012-05-23 不批准

CYHB0813096

厄贝沙坦片

补充申请2009-02-

04

江苏恒瑞医药股份有限公司


2009-07-29 批准临床

CYHS0900237

厄贝沙坦仿制 62009-06-

18

浙江金立源药业有

限公司


2011-04-15 批准生产

CYHS0900380

厄贝沙坦仿制 62009-09-

09

珠海润都民彤制药有限公司


2011-09-29 批准生产

CYHS0900877

厄贝沙坦仿制 62009-12-

21

浙江天宇药业有限

公司


2010-11-23 批准生产

CXHS0900294


新药 52010-01-

15


公司


2011-04-15 批准生产

CYHS0901016

厄贝沙坦仿制 62010-01-

25

浙江普洛家园药业有限公司


2012-03-30 批准生产

CYHB1090015

厄贝沙坦片

补充申请2010-06-

08



2011-02-12 批准补充

CYHB1005156

厄贝沙坦片

补充申请2010-07-

14

扬子江药业集团北京海燕药业有限公

司


2010-11-23 批准补充

CYHS1000163

厄贝沙坦片

仿制 62010-07-

15

宜昌人福药业有限责任公司


2013-01-10 批准临床

CYHS1000164

厄贝沙坦片

仿制 62010-07-

15



2013-01-10 批准临床

https://db.yaozh.com/zhuce/bp2Xamk=.html

https://db.yaozh.com/zhuce/bp2Xamo=.html

https://db.yaozh.com/zhuce/ZpSRb2pn.html

https://db.yaozh.com/zhuce/ZpSUbWVp.html

https://db.yaozh.com/zhuce/ZpSVZ2Fi.html

https://db.yaozh.com/zhuce/ZpSVZ2Fo.html

https://db.yaozh.com/zhuce/ZpSVaGVk.html

https://db.yaozh.com/zhuce/ZpSYbmFk.html

https://db.yaozh.com/zhuce/ZpSabGpm.html

https://db.yaozh.com/zhuce/ZpWSb2dr.html

https://db.yaozh.com/zhuce/ZpWTampl.html

https://db.yaozh.com/zhuce/ZpWTbGpj.html

https://db.yaozh.com/zhuce/ZpWWZ2Ro.html

https://db.yaozh.com/zhuce/ZpWWbWlm.html

https://db.yaozh.com/zhuce/ZpWWbmRn.html

https://db.yaozh.com/zhuce/ZpWWbmRo.html




CYHS1000162

厄贝沙坦片

仿制 62010-07-

15



2013-01-10 批准临床

CYHB1006593

厄贝沙坦片

补充申请2010-09-

10

赛诺菲安万特(杭

州）制药有限公司


2013-03-01 批准临床

CYHS1000502

厄贝沙坦片

仿制 62010-10-

18

宜昌长江药业有限

公司


2016-07-21

CYHS1000712

厄贝沙坦片

仿制 62010-10-

22

四川省通园制药有

限公司


2012-08-06 批准临床

CYHB1090030

厄贝沙坦片

补充申请2010-11-

24

江苏恒瑞医药股份有限公司


2012-02-09 批准补充

JYHB1001067

厄贝沙坦片

补充申请2010-12-

03-


2011-06-08 批准补充

JYHB1001068

厄贝沙坦片

补充申请2010-12-

03-


2011-06-08 批准补充

CYHS1000605

厄贝沙坦片

仿制 62011-02-

10

浙江为康制药有限

公司


2014-03-28 批准临床

CYHB1016128

厄贝沙坦片

补充申请2011-02-

12

赛诺菲安万特(杭

州）制药有限公司


2011-09-22终止审批

程序

CYHS1100254

厄贝沙坦胶囊

仿制 62011-06-

03

华益药业科技（安徽）有限

公司


2015-09-23

JXHS1100091

厄贝沙坦进口2011-08-

12

赛诺菲（中国）投资有限

公司

在审评审批中 2011-08-11

CYHB1104112


14

修正药业集团柳河制药有限

公司


2012-04-18 不批准

CYHS1001086

厄贝沙坦片

仿制 62011-09-

29

吉林吉春制药有限

公司


2015-09-23 不批准

CYHS1100159

厄贝沙坦片

仿制 62011-11-

14

吉林省康福药业有

限公司


2015-09-23 不批准

CYHS1101622

厄贝沙坦片

仿制 62012-03-

23

正大青春宝药业有

限公司


2015-11-19 批准临床

https://db.yaozh.com/zhuce/ZpWWbmRp.html

https://db.yaozh.com/zhuce/ZpWXbWdo.html

https://db.yaozh.com/zhuce/ZpWYaWhj.html

https://db.yaozh.com/zhuce/ZpWYamlr.html

https://db.yaozh.com/zhuce/ZpWZZ2Jj.html

https://db.yaozh.com/zhuce/ZpWZaGdj.html

https://db.yaozh.com/zhuce/ZpWZaGdk.html

https://db.yaozh.com/zhuce/ZpWaaGpn.html

https://db.yaozh.com/zhuce/ZpWaamJm.html

https://db.yaozh.com/zhuce/ZpaSb2Zo.html

https://db.yaozh.com/zhuce/ZpaUaGlp.html

https://db.yaozh.com/zhuce/ZpaUbWZk.html

https://db.yaozh.com/zhuce/ZpaVZ2Jq.html

https://db.yaozh.com/zhuce/ZpaVb2Jr.html

https://db.yaozh.com/zhuce/ZpaYaWZp.html




CYHB1200875

厄贝沙坦片

补充申请2012-03-

31

赛诺菲(杭州）

制药有限公司

在审评审批中 2012-03-29

CYHB1111564


补充申请2012-04-

17


公司


2013-01-10 批准补充

JYHB1200427

厄贝沙坦片

补充申请2012-05-

03-


2012-12-26 批准补充

JYHB1200425

厄贝沙坦片

补充申请2012-05-

03-


2012-12-26 批准补充

JYHB1200426

厄贝沙坦片

补充申请2012-05-

03-


2012-12-26 批准补充

CYHS1101206

厄贝沙坦片

仿制 62012-06-

07

江苏万高药业有限

公司


2015-12-02 批准临床

CYHB1100149

厄贝沙坦胶囊

补充申请2012-09-

10

浙江弘盛药业有限

公司


2013-03-22

CYHB1203154

厄贝沙坦胶囊

补充申请2012-09-

26哈药集团制药六厂


2013-04-11 批准临床

CYHS1200830

厄贝沙坦胶囊

仿制 62012-11-

12

海南澳美华制药有

限公司


2015-09-23

CYHS1200793

厄贝沙坦片

仿制 62013-04-

10

辰欣药业股份有限

公司


2015-12-24 批准临床

CYHS1201894

厄贝沙坦片

仿制 62013-07-

25

吉林一正药业集团有限公司


2016-01-14 批准临床

CYHB1300227

厄贝沙坦片

补充申请2013-07-

30


司


2014-05-23

CYHB1300226

厄贝沙坦片

补充申请2013-07-

30


司


2014-05-23

CYHS1390072

厄贝沙坦片

仿制 62013-10-

30

四川省通园制药有

限公司


2016-01-29 企业撤回

CYHS1301401

厄贝沙坦片

仿制 62014-01-

15

上海皇象铁力蓝天制药有限

公司


2016-01-14 批准临床

https://db.yaozh.com/zhuce/ZpaYa2Nn.html

https://db.yaozh.com/zhuce/ZpaYcGRj.html

https://db.yaozh.com/zhuce/ZpaZaWVk.html

https://db.yaozh.com/zhuce/ZpaZaWVl.html

https://db.yaozh.com/zhuce/ZpaZaWVm.html

https://db.yaozh.com/zhuce/ZpaZcGRp.html

https://db.yaozh.com/zhuce/ZpeRb2lk.html

https://db.yaozh.com/zhuce/ZpeSaWFq.html

https://db.yaozh.com/zhuce/ZpeTZ2Rp.html

https://db.yaozh.com/zhuce/ZpeVb2pi.html

https://db.yaozh.com/zhuce/ZpeYamFm.html

https://db.yaozh.com/zhuce/ZpeYamVr.html

https://db.yaozh.com/zhuce/ZpeYamZi.html

https://db.yaozh.com/zhuce/ZpeaamVr.html

https://db.yaozh.com/zhuce/ZpiSbGFi.html




CXb01108厄贝沙坦

片补充申请 2

2001-04-13

江苏扬子江药业集

团公司已发批件 2002-03-15

CXb20020249

厄贝沙坦补充申请 22002-04-

17

深圳市海滨制药有

限公司已发批件 2003-05-16 批准

CXb20020250

厄贝沙坦片

补充申请 22002-04-

17


限公司已发批件 2003-05-16 批准

CXB20020251

厄贝沙坦片

申请新药补充

2002-04-17


限公司已发批件 2003-05-16 批准生产

CXb01088厄贝沙坦

片补充申请 2

2001-03-23


限公司已发批件 2002-03-13 批准生产

JYHB1400248


12

CHINOIN

Pharmaceutical

andChemic

alWorksPrivateCo.,Ltd

审批完毕 2014-11-17

CYHS1301815

厄贝沙坦仿制 62014-04-

21

宜昌长江药业有限

公司


2017-12-14

CYHS1301589

厄贝沙坦片

仿制 62014-06-

20

广东东阳光药业有

限公司


2016-09-26 批准临床

CYHS1301588

厄贝沙坦片

仿制 62014-06-

20


限公司


2016-09-26 批准临床

CYHS1301590

厄贝沙坦片

仿制 62014-06-

20


限公司


2016-09-26 批准临床

CYHB1404996

厄贝沙坦片

补充申请2014-07-

30



2015-01-15

CYHB1403953

厄贝沙坦胶囊

补充申请2014-08-



2015-01-15

JYHB1401084

厄贝沙坦片

补充申请2014-08-

26


公司


2015-01-23

JYHB1401085

厄贝沙坦片

补充申请2014-08-

26


公司


2015-01-23

https://db.yaozh.com/zhuce/ZpiUbmJi.html

https://db.yaozh.com/zhuce/ZpiUcGVj.html

https://db.yaozh.com/zhuce/ZpiUcGVk.html

https://db.yaozh.com/zhuce/ZpiUcGVl.html

https://db.yaozh.com/zhuce/ZpiVaGdp.html

https://db.yaozh.com/zhuce/ZpiVa2li.html

https://db.yaozh.com/zhuce/ZpiWa2Zl.html

https://db.yaozh.com/zhuce/ZpiYaGhj.html

https://db.yaozh.com/zhuce/ZpiYaGhk.html

https://db.yaozh.com/zhuce/ZpiYaGhl.html

https://db.yaozh.com/zhuce/ZpiZbGJq.html

https://db.yaozh.com/zhuce/ZpiaaGll.html

https://db.yaozh.com/zhuce/Zpiaa2Nk.html

https://db.yaozh.com/zhuce/Zpiaa2Nm.html




JYHB1401086

厄贝沙坦片

补充申请2014-08-

26


公司


2015-01-23

JYHB1401087

厄贝沙坦片

补充申请2014-08-

26


公司


2015-01-23

JYHB1401088

厄贝沙坦片

补充申请2014-08-

26


公司


2015-01-23

JYHB1401083

厄贝沙坦片

补充申请2014-08-

26


公司


2015-01-23

CYHB1406740


04

修正药业集团柳河制药有限

公司


2015-08-11 不批准

JYHB1500033

厄贝沙坦颗粒

补充申请2015-01-

19Sanofi

Clir SNC制证完毕－已

发批件2016-06-01

CYHS1590003

厄贝沙坦片

仿制 62015-02-

03

浙江为康制药有限

公司


2016-01-21 企业撤回

JYHB1500225

厄贝沙坦片

补充申请2015-03-

04


公司


2016-06-15

JYHB1500226

厄贝沙坦片

补充申请2015-03-

04


公司


2016-06-15

JYHB1500227

厄贝沙坦片

补充申请2015-03-

04


公司


2016-06-15

JYHB1500228

厄贝沙坦片

补充申请2015-03-

04


公司


2016-06-15

JYHB1500229

厄贝沙坦片

补充申请2015-03-

04


公司


2016-06-15

JYHB1500230

厄贝沙坦片

补充申请2015-03-

04


公司


2016-06-15

https://db.yaozh.com/zhuce/Zpiaa2No.html

https://db.yaozh.com/zhuce/Zpiaa2Ri.html

https://db.yaozh.com/zhuce/Zpiaa2Rm.html

https://db.yaozh.com/zhuce/Zpiaa2Rq.html

https://db.yaozh.com/zhuce/Zpiabmdj.html

https://db.yaozh.com/zhuce/ZpmTcGFo.html

https://db.yaozh.com/zhuce/ZpmVaWRk.html

https://db.yaozh.com/zhuce/ZpmVb2Zr.html

https://db.yaozh.com/zhuce/ZpmVb2di.html

https://db.yaozh.com/zhuce/ZpmVb2dj.html

https://db.yaozh.com/zhuce/ZpmVb2dk.html

https://db.yaozh.com/zhuce/ZpmVb2dl.html

https://db.yaozh.com/zhuce/ZpmVb2dm.html




JYHB1500231

厄贝沙坦片

补充申请2015-03-

04


公司


2016-06-15

JYHB1500232

厄贝沙坦片

补充申请2015-03-

04


公司


2016-06-15

CYHS1400708


仿制 62015-04-

09

海南海力制药有限

公司


2016-03-01 批准临床

JYHB1500612

厄贝沙坦片

补充申请2015-05-

12


公司


2016-05-24

JYHB1500613

厄贝沙坦片

补充申请2015-05-

12


公司


2016-05-24

JYHB1500614

厄贝沙坦片

补充申请2015-05-

12


公司


2016-05-24

JYHB1500616

厄贝沙坦片

补充申请2015-05-

12


公司


2016-05-24

JYHB1500617

厄贝沙坦片

补充申请2015-05-

12


公司


2016-05-24

JYHB1500615

厄贝沙坦片

补充申请2015-05-

12


公司


2016-05-24

JXHS1500052

厄贝沙坦进口2015-05-

29

肇庆市定康药业有

限公司在审评审批中 2015-05-27

CYHS1400694

厄贝沙坦片

仿制 62015-07-

13

山东司邦得制药有

限公司


2016-06-07 批准临床

CYHB1590014

厄贝沙坦胶囊

补充申请2015-07-



2016-05-31 企业撤回

CYHS1401417


仿制 62015-11-

20

山东仙河药业有限

公司


2016-08-01 批准临床

CYHS1401418


仿制 62015-11-

20

山东仙河药业有限

公司


2016-08-01 批准临床

https://db.yaozh.com/zhuce/ZpmVb2dn.html

https://db.yaozh.com/zhuce/ZpmVb2do.html

https://db.yaozh.com/zhuce/ZpmWbWZl.html

https://db.yaozh.com/zhuce/ZpmXbWNj.html

https://db.yaozh.com/zhuce/ZpmXbWNk.html

https://db.yaozh.com/zhuce/ZpmXbWNl.html

https://db.yaozh.com/zhuce/ZpmXbWNm.html

https://db.yaozh.com/zhuce/ZpmXbWNn.html

https://db.yaozh.com/zhuce/ZpmXbWNo.html

https://db.yaozh.com/zhuce/ZpmYaWRo.html

https://db.yaozh.com/zhuce/ZpmZamhi.html

https://db.yaozh.com/zhuce/ZpmZbmdm.html

https://db.yaozh.com/zhuce/ZpqSZ2Fq.html

https://db.yaozh.com/zhuce/ZpqSZ2Fr.html




CYHS1501333

厄贝沙坦片

仿制 62015-12-

07

浙江金立源药业有

限公司


2016-08-04 批准临床

CYHS1500513

厄贝沙坦片

仿制 62016-01-

05

陕西东泰制药有限

公司


2016-10-27 批准临床

CYHS1600024


仿制 62016-08-

31

珠海润都制药股份有限公司

在审批 2017-06-19批准临床(待核实)

CYHB1606261


26

浙江天宇药业股份有限公司


2017-09-14 批准补充

CYHB1702594


25


在审评审批中 2017-05-23

CYHB1703366

厄贝沙坦片

补充申请2017-09-

25



2017-12-29 批准生产

CYHB1704196

厄贝沙坦片

补充申请2017-09-

25

海正辉瑞制药有限

公司


2017-12-29 批准生产

CYHB1704197

厄贝沙坦片

补充申请2017-09-

25


公司


2017-12-29 批准生产

CYHB1704195

厄贝沙坦片

补充申请2017-09-

25


公司


2017-12-29 批准生产

JYHZ1700097

厄贝沙坦片

进口再注册

2017-08-24


公司


2017-09-28批准再注

册

JYHZ1700098

厄贝沙坦片

进口再注册

2017-08-24


公司


2017-09-28批准再注

册

JYHZ1700099

厄贝沙坦片

进口再注册

2017-08-24


公司


2017-09-28批准再注

册

JYHZ1700100

厄贝沙坦片

进口再注册

2017-08-24


公司


2017-09-28批准再注

册

JYHZ1700101

厄贝沙坦片

进口再注册

2017-08-24


公司


2017-09-28批准再注

册

https://db.yaozh.com/zhuce/ZpqSaWRk.html

https://db.yaozh.com/zhuce/ZpqSbmFj.html

https://db.yaozh.com/zhuce/ZpqVbGRm.html

https://db.yaozh.com/zhuce/ZpqWbmlj.html

https://db.yaozh.com/zhuce/ZpqYZ2Ni.html

https://db.yaozh.com/zhuce/ZpqYcGFn.html

https://db.yaozh.com/zhuce/ZpqZaGRj.html

https://db.yaozh.com/zhuce/ZpqZaGRk.html

https://db.yaozh.com/zhuce/ZpqZaGRl.html

https://db.yaozh.com/zhuce/ZpqZa2pj.html

https://db.yaozh.com/zhuce/ZpqZa2pk.html

https://db.yaozh.com/zhuce/ZpqZa2pl.html

https://db.yaozh.com/zhuce/ZpqZa2pm.html

https://db.yaozh.com/zhuce/ZpqZa2pn.html




JYHZ1700102

厄贝沙坦片

进口再注册

2017-08-24


公司


2017-09-28批准再注

册

JYHZ1700103

厄贝沙坦片

进口再注册

2017-08-24


公司


2017-09-28批准再注

册

JYHZ1700104

厄贝沙坦片

进口再注册

2017-08-24


公司


2017-09-28批准再注

册

JYHF1700117

厄贝沙坦片

补充申请2017-11-

30

赛诺菲(杭州)制药有限公

司


2018-01-04

JYHF1700116

厄贝沙坦片

补充申请2017-11-

30

赛诺菲(杭州)制药有限公

司


2018-01-04

申请类型

数量

新药进口进口再注册仿制补充申请其他0

25

50

75

100

https://db.yaozh.com/zhuce/ZpqZa2po.html

https://db.yaozh.com/zhuce/ZpqZa2pp.html

https://db.yaozh.com/zhuce/ZpqZa2pq.html

https://db.yaozh.com/zhuce/ZpqacGNk.html

https://db.yaozh.com/zhuce/ZpqacGNl.html



药品名称标准来源页码查看全文/文件下载

厄贝沙坦胶囊新药转正标准62 下载

厄贝沙坦片新药转正标准61 下载

厄贝沙坦新药转正标准61 下载

厄贝沙坦颗粒进口药品复核标准汇编2002年查看

厄贝沙坦国家药监局单页标准（2000）查看

剂型

数量

原料药片剂片剂（缓控… 胶囊颗粒剂0

25

50

75

100

125

承办日期

数量

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

0

5

10

15

20

25

药品标准(76条) 隐藏

http://zy.yaozh.com/biaozhun/xyzz62/00027.pdf



https://db.yaozh.com/biaozhun/18523.html





厄贝沙坦片国家药监局单页标准（2000）查看









厄贝沙坦胶囊国家药监局单页标准（2000）查看













厄贝沙坦国监局单页标准(化学药2000) 查看

厄贝沙坦片国监局单页标准(化学药2000) 查看

厄贝沙坦胶囊国监局单页标准(化学药2000) 查看























































伊贝沙坦片进口药品复核标准汇编2000年查看

厄贝沙坦胶囊国家药监局单页标准(2002)

厄贝沙坦国家药监局单页标准(2002)

厄贝沙坦片进口药复核标准汇编(2003) 571 查看

厄贝沙坦分散片国家药监局标准颁布件(2011) 查看

厄贝沙坦片进口药品单页标准

厄贝沙坦片赛诺菲进口药品单页标准

厄贝沙坦进口药品单页标准 0

厄贝沙坦中国药典2010版第三增补本 104 下载

厄贝沙坦片中国药典2010版第三增补本 106 下载

厄贝沙坦分散片中国药典2010版第三增补本 106 下载

厄贝沙坦胶囊中国药典2010版第三增补本 107 下载

厄贝沙坦胶囊其他查看

厄贝沙坦片其他查看

厄贝沙坦中国药典2015年版二部 70 下载

厄贝沙坦分散片中国药典2015年版二部 73 下载

厄贝沙坦片中国药典2015年版二部 72 下载

厄贝沙坦胶囊中国药典2015年版二部 73 下载

Irbesartan USP28-NF23 查看



Irbesartan BP2013 查看

Irbesartan USP36-NF31 3967 查看


Irbesartan BP2015 I-1252, V-S76













http://zy.yaozh.com/biaozhun/zgyddszb/yddszb_88.pdf






http://zy.yaozh.com/biaozhun/2015yd02/yaodian00112.pdf




http://zy.yaozh.com/foreign/USP28/USP%20Monographs/I/Irbesartan.htm

http://zy.yaozh.com/foreign/usp32/pub/data/v32270/usp32nf27s0_m42410.html

http://zy.yaozh.com/foreign/usp35/2021-5089%20USP%20Monographs/3556-3557%20Irbesartan.pdf

http://zy.yaozh.com/foreign/bp2013/Irbesartan.pdf

http://zy.yaozh.com/foreign/usp36/Split_04704.pdf

http://zy.yaozh.com/foreign/USP38/Irbesartan.pdf

http://zy.yaozh.com/foreign/usp39/Irbesartan.pdf




Irbesartan EP7.0 394 查看



药品名称来源更新时间操作

厄贝沙坦片国家药监局公布第二批化学药品说

明书

查看全文

厄贝沙坦胶囊哈药集团制药六厂下载1

厄贝沙坦片江苏恒瑞医药股份有限公司查看全文

厄贝沙坦片赛诺菲（杭州）制药有限公司下载1

厄贝沙坦片修正药业集团下载1

厄贝沙坦分散片淮坊中狮制药有限公司下载1

厄贝沙坦胶囊浙江弘盛药业有限公司下载1




厄贝沙坦片浙江华海药业股份有限公司下载1

イルベサルタン錠50mg「トーワ」, イルベサルタン錠100mg「トーワ」, イルベサルタン錠200mg「トーワ」

製造販売:東和薬品/販売：三和化学研究所/

查看

イルベサルタン錠50mg「共創未来」, イルベサルタン錠100mg「共創未来」, イルベサルタン錠200mg「共創未来」

製造販売:共創未来ファーマ/ 查看

イルベサルタン錠50mg「サワイ」, イルベサルタン錠100mg「サワイ」, イルベサルタン錠200mg「サワイ」

製造販売:沢井製薬/ 查看

イルベサルタン錠50mg「ニプロ」, イルベサルタン錠100mg「ニプロ」, イルベサルタン錠200mg「ニプロ」

製造販売:ニプロ/ 查看

イルベサルタン錠50mg「KN」, イルベサルタン錠100mg「KN」, イルベサルタン錠200mg「KN」

製造販売:小林化工/ 查看

イルベサルタン錠50mg「ケミファ」, イルベサルタン錠100mg「ケミファ」, イルベサルタン錠200mg「ケミファ」

製造販売:日本ケミファ/ 查看

药品说明书(36条) 隐藏

http://zy.yaozh.com/foreign/EP7.0/2465E.pdf

http://zy.yaozh.com/foreign/EP7.5/Irbesartan.pdf

http://zy.yaozh.com/foreign/EP/EP03113.pdf

https://db.yaozh.com/instruct/49346.html

http://zy.yaozh.com/instruct/hlj/7916a18d4b454e52eebab09f70b64a538e10.jpg

https://db.yaozh.com/instruct/103125.html

http://zy.yaozh.com/instruct/ypsms15820/47.pdf

http://zy.yaozh.com/instruct/sms102016/7.jpg

http://zy.yaozh.com/instruct/20160513-1/22.jpg

http://zy.yaozh.com/instruct/sms20170328/1241417540556-%E5%8E%84%E8%B4%9D%E6%B2%99%E5%9D%A6%E8%83%B6%E5%9B%8A%E8%AF%B4%E6%98%8E%E4%B9%A6.rar

http://zy.yaozh.com/instruct/sms20170328/1470387612640-Aprovel_spec_LRP_PI.zip

http://zy.yaozh.com/instruct/sms20170328/1470387125808-Aprovel_spec_LRP_PI.zip

http://zy.yaozh.com/instruct/sms20170328/1465790782014-%E5%8E%84%E8%B4%9D%E6%B2%99%E5%9D%A6%E7%89%87-PI-ChP2015.zip

http://zy.yaozh.com/instruct/sms20170328/1466061930421-%E8%AF%B4%E6%98%8E%E4%B9%A6.zip

http://zy.yaozh.com/data/pdf/00067172.pdf








药品名称来源更新时间操作

イルベサルタン錠50mg「DSPB」, イルベサルタン錠100mg「DSPB」, イルベサルタン錠200mg「DSPB」

製造販売:DSファーマバイオメディカル/販売：大日本住友製薬/

查看

イルベサルタンOD錠50mg「トーワ」, イルベサルタンOD錠100mg「トーワ」, イルベサルタンOD錠200mg「トーワ」

製造販売:東和薬品/ 查看

イルベサルタン錠50mg「トーワ」, イルベサルタン錠100mg「トーワ」, イルベサルタン錠200mg「トーワ」

製造販売:東和薬品/ 查看

イルベサルタン錠50mg「日医工」, イルベサルタン錠100mg「日医工」, イルベサルタン錠200mg「日医工」

製造販売:日医工/ 查看

イルベサルタン錠50mg「オーハラ」, イルベサルタン錠100mg「オーハラ」, イルベサルタン錠200mg「オーハラ」

製造販売:大原薬品工業/販売：日本ジェネリック/

查看

イルベサルタン錠50mg「オーハラ」, イルベサルタン錠100mg「オーハラ」, イルベサルタン錠200mg「オーハラ」

製造販売:大原薬品工業/ 查看

イルベサルタン錠50mg「EE」, イルベサルタン錠100mg「EE」,イルベサルタン錠200mg「EE」

製造販売:エルメッドエーザイ/ 查看

アバプロ錠50mg, アバプロ錠100mg, アバプロ錠200mg 製造販売:大日本住友製薬/ 查看

イルベタン錠50mg, イルベタン錠100mg, イルベタン錠200mg 製造販売:塩野義製薬/ 查看

AVAPRO SANOFI AVENTIS US2006-04-25










注册题目干预措施招募状态研究疾病研究阶段国家开始时间

全球临床试验情况(88条) 隐藏












ClinicalTrial ofHuangKuiCapsuleto TreatDiabeticKidneyDisease

Drug:Placebo drugthat simulates

Irbesartantablets;Drug:irbesart

antablets;Drug:Placebodrug that simulates

HuangKuicapsule;Drug:Huang

Kui Capsule

RecruitingDiabetic Kidney

DiseaseEarly

Phase 1China 2017-01-01

ObservationalStudy ofAzilsartan/Chlorthalidone andIrbesartan/Hydrochlorothiazide inHypertension andObesity.

RecruitingArterial

HypertensionRussian

Federation2017-01-01

Evaluation of theFixed-doseCombination ofIrbesartan/Atorvastatin inType 2DiabeticPatientsDiagnosed WithHyperlipidemiaandHypertension

Drug:Irbesartan/atorvastatin fixed dose

combination;Drug:Irbesartan

SR47436;Drug:Atorvastatin

RecruitingType 2 Diabetes

MellitusPhase 4

Korea,Republic of

2016-08-23

Remission Clinic inProteinuric ChronicNephropathies

Drug:Ramipril,Irbesartan and

AtorvastinRecruiting

Chronic KidneyDisease

Italy 2009-06-01

https://db.yaozh.com/clinical/bpqZbQ==.html

https://db.yaozh.com/clinical/ZpSVbGg=.html

https://db.yaozh.com/clinical/Z5eRb2U=.html

https://db.yaozh.com/clinical/aJaUbWY=.html



AProspective,Single-center,Randomized,Controlled StudyofSevelamerCarbonate in theLipidMetabolism andUric AcidTreatment ofObesity-RelatedGlomerulopathy

Drug:High dosageSevelamer

Carbonate +Irbesartan;Drug:Lowdosage Sevelamer

Carbonate +Irbesartan;Drug:Irbe

sartan

RecruitingObesity and

GlomerulopathyChina 2016-01-01

Angiotensin IIReceptorBlockadeinVascularEhlersDanlosSyndrome(ARCADE)

Drug:Irbesartan;Drug:Placebo

RecruitingEhlers-Danlos

Syndrome,Vascular Type

Phase 3 France 2016-01-01

Effectiveness ofAvapro inObeseNormotensive/HypertensiveAfricanAmericans


Recruiting

Hypertension;Obesity;Stress,

Psychological;Blood Pressure

Phase 2 United States 2014-09-01

MultipleTreatments forEbolaVirusDisease(EVD)

Drug:Azithromycin;Drug:Sunitinib and

Erlotinib;Drug:Atorvastatin and

Irbesartan;Other:IVfluids and laboratory

testing

Unknownstatus

Ebola VirusDisease

Phase1/Phase

22015-04-01

Angiotensin IIAntagonist inSevereSepsis

Drug:IrbesartanUnknown

statusSevere Sepsis Phase 3 Italy 2014-01-01

https://db.yaozh.com/clinical/aJyTbGc=.html

https://db.yaozh.com/clinical/aZWZbWM=.html

https://db.yaozh.com/clinical/apyRbGM=.html

https://db.yaozh.com/clinical/apyVb2k=.html

https://db.yaozh.com/clinical/bZyTZ2Q=.html



PharmacokineticDrugInteraction StudyBetweenGemigliptin andIrbesartanAfter OralAdministration inHealthyMaleSubjects

Drug:Gemigliptin;Drug:Irbesartan

Completed Healthy Phase 1Korea,

Republic of2013-06-01

CrossoverBioequivalenceStudy ofIrbesartanHCTZ300/25mgTabletsUnderFastedConditions

Drug:Irbesartan andHydrochlorothiazide

;Drug:AvalideCompleted Hypertension United States 2007-09-01

CrossoverBioequivalenceStudy ofIrbesartanHydrochlorothiazide300/25mgTabletsUnderFedConditions

Drug:Irbesartan andHydrochlorothiazide

;Drug:AvalideCompleted Hypertension United States 2007-09-01

CrossoverBioequivalenceStudy ofIrbesartan300 mgTabletsUnderFastedConditions

Drug:Irbesartan;Drug:Avapro

Completed Hypertension United States 2007-08-01

https://db.yaozh.com/clinical/bpSab2I=.html

https://db.yaozh.com/clinical/bp2XcGQ=.html

https://db.yaozh.com/clinical/bp2XcGU=.html

https://db.yaozh.com/clinical/bp2XcGY=.html



CrossoverBioequivalenceStudy ofIrbesartan300 mgTabletsUnderFedConditions

Drug:Irbesartan;Drug:Avapro

Completed Hypertension United States 2007-08-01

Sevelamer inProteinuric CKD

Drug:Sevelamer;Drug:Ramipril and

IrbesartanCompleted

Chronic KidneyDisease

Phase 2 Italy 2013-10-01

TheOxfordMarfanTrial

Drug:Irbesartan 150-300mg capsules

daily for 6months;Drug:Doxycy

cline 100-200mgcapsules daily for 6

months;Drug:Doxycycline placebo

capsules daily for 6months;Drug:Irbesartan placebo capsules

daily for 6 months

RecruitingMarfan

SyndromePhase 2

UnitedKingdom

2013-10-01

DrugInteractionBetweenIrbesartanandHydrochlorothiazide

Drug:Irbeasartan/hydrochlorothiazide;Drug:Irbesartan;Drug:H

ydrochlorothiazide

Completed Healthy Egypt 2013-03-01

Study ofEfficacyandSafety ofIrbesartan/Amlodipine 4FixedCombinationTherapyinHypertensivePatientsUncontrolled onIrbesartanorAmlodipineMonotherapy

Drug:Irbesartan/Amlodipine

(150/5mg);Drug:Irbesartan/Amlodipine

(150/10mg);Drug:Irbesartan/Amlodipine(300/5mg);Drug:Irbesartan/Amlodipine

(300/10mg)

Completed Hypertension Phase 3Russian

Federation2012-05-01

https://db.yaozh.com/clinical/bp2XcGc=.html

https://db.yaozh.com/clinical/ZpSRZ2Vj.html

https://db.yaozh.com/clinical/ZpSSbGRp.html

https://db.yaozh.com/clinical/ZpSZa2ho.html

https://db.yaozh.com/clinical/ZpWXaWdk.html



Randomized,Double-Blind,SafetyandEfficacyStudy ofRE-021(Sparsentan) inFocalSegmentalGlomerulosclerosis

Drug:RE-021(Sparsentan);Drug:Ir

besartan

Active, notrecruiting

Focal SegmentalGlomeruloscleros

isPhase 2

UnitedStates;Belgiu

m;CzechRepublic;Italy

2013-12-01

Preeclampsia: AMarkerfor FutureCardiovascular RiskinWomen

Drug:Irbesartan RecruitingPreeclampsia;Pregnancy Induced

HypertensionUnited States 2012-05-01

ABioequivalenceStudyComparingIrbesartan/AtorvastatinCombination TabletWithCoadministrationofIrbesartanandAtorvastatin

Drug:HCP0912 /Irbesartan and

AtorvastatinCompleted Healthy Phase 1

Korea,Republic of

2011-09-01

EfficacyandSafety ofIrbesartanandAtorvastatin inHypertension andHyperlipidemia

Drug:Irbesartan/Atorvastatin

A;Drug:Irbesartan;Drug:Atorvastatin

A;Drug:Placebo;Drug:Irbesartan/Atorvast

atinB;Drug:Atorvastatin

B

CompletedHypertension;Hy

perlipidemiaPhase 3

Korea,Republic of

2011-05-01

https://db.yaozh.com/clinical/ZpWYaWFq.html

https://db.yaozh.com/clinical/ZpaVamhr.html

https://db.yaozh.com/clinical/Zpaab2Vm.html

https://db.yaozh.com/clinical/ZpeRaWFi.html



The EffectofMoxonidine onBloodPressureandRegression of EarlyTargetOrganDamagein YoungSubjectsWithAbdominal ObesityandHypertension

Drug:Moxonidine;Drug:Irbesartan

Unknownstatus

AbdominalObesity;Hyperte

nsionPhase 4 Australia 2012-01-01

CombinedAntihypertensiveTherapyandSexualDysfunction

Drug:Felodipine addIrbesartan;Drug:Felo

dipine addMetoprolol

Unknownstatus

Hypertension;Sexual Dysfunction

Phase 4 China 2008-04-01

JiangzhuoQingganPrescription andIrbesartanin theTreatment ofEssentialHypertension(HepatogastricDamp-heat)Clinical Study

Unknownstatus

Hypertension;Metabolic

SyndromeChina 2010-03-01

IrbesartanVersusAmlodipine: TheOBI Study

Drug:Irbesartan;Drug:Amlodipine

WithdrawnObesity;Hyperte

nsionPhase 4 Greece 2012-01-01

https://db.yaozh.com/clinical/ZpeXa2lm.html

https://db.yaozh.com/clinical/ZpiWbmlm.html

https://db.yaozh.com/clinical/ZpmYbWlo.html

https://db.yaozh.com/clinical/ZpqVb2pi.html



Irbesartan/Amlodipine inHypertensivePatientsUncontrolled onIrbesartan150 mgMonotherapy

Drug:irbesartan/amlodipine;Drug:irbesar

tanCompleted Hypertension Phase 3

Brazil;Colombia;Guatemala;Mexico;Morocco;Tunisia;U

nited ArabEmirates;Ven

ezuela

2009-07-01

Irbesartan/Amlodipine inHypertensivePatientsUncontrolled onAmlodipine 5 mgMonotherapy

Drug:irbesartan/amlodipine;Drug:amlodi

pineCompleted Hypertension Phase 3

Brazil;Chile;Colombia;Egypt;Lebanon;Mexico;Morocco;Tunisia;Venez

uela

2009-07-01

IrbesartanandAmlodipineCombination inControlling BloodPressure

Drug:IRBESARTAN(SR47436);Drug:Amlodipine;Drug:Irbesar

tan /Amlodipine;Drug:Pla

cebo

Completed Hypertension Phase 2

India;Korea,Republic

of;Philippines;Taiwan

2009-07-01

Comparison ofStandardVersusLow DoseAdvagraf® WithorWithoutAngiotensin-converting EnzymeInhibitor(ACEi)/AngiotensinReceptorBlocker(ARB) onHistologyandFunctionof RenalAllografts

Drug:Advagraf;Drug:Advagraf;Biological:Simulect;Drug:Cellcept;Drug:Corticosteroids;Drug:Ramipril;Dr

ug:Irbesartan


KidneyTransplantation

Phase 3 Canada 2009-06-01

https://db.yaozh.com/clinical/ZpqYaGZr.html

https://db.yaozh.com/clinical/ZpqYaWNp.html

https://db.yaozh.com/clinical/ZpqYbmNp.html

https://db.yaozh.com/clinical/ZpqaZ2Jo.html



Irbesartan-Hydrochlorothiazide PhaseIV Study:Treatment ofHypertension inChinesePopulation

Drug:Irbesartan150mg /

Hydrochlorothiazide12.5mg;Drug:Irbesar

tan 150mg

Completed Hypertension Phase 4 China 2003-12-01

AggressiveTreatment ofMetabolicSyndrome inPatientsReceivingClozapineforSchizophrenia

Drug:Pravastatin,Fenofibrate,

Metformin, Orlistat,irbesartan;Other:As

selected bycommunityphysician

TerminatedMetabolicSyndrome

United States 2008-11-01

SavingResidualRenalFunctionAmongHaemodialysisPatientsReceivingIrbesartan

Drug:Irbesartan;Drug:Placebo matchingirbesartan 150 mg

CompletedKidney Failure,

ChronicPhase 3 Denmark 2009-04-01

Role ofAT1-receptorBlockersin Insulin-inducedVasodilation.

Drug:Irbesartan;Drug:Felodipine;Drug:Pl

acebo

Unknownstatus

Hypertension;Insulin

Resistance;Microcirculation

Netherlands 2008-03-01

ACTUAL:EfficacyandSafety ofIrbesartan/HydrochlorothiazideCombination

Drug:Irbesartan -Hydrochlorothiazide

;Drug:Irbesartan -Hydrochlorothiazide


Algeria;Argentina;Brazil;Colombia;Ecuador;Egypt;Guatemala;Lebanon;Mexico;Morocco;Panama;

Peru;SaudiArabia;Tunisia;United ArabEmirates;Ven

ezuela

2008-06-01

https://db.yaozh.com/clinical/ZpuWa2Vm.html

https://db.yaozh.com/clinical/Zpuaa2Zm.html

https://db.yaozh.com/clinical/ZpuabWlp.html

https://db.yaozh.com/clinical/ZpyUa2Zr.html

https://db.yaozh.com/clinical/ZpyXZ2Nj.html



Irbesartan/Hydrochlorothiazide toControlElevatedBloodPressureto TargetinModerateto SevereHypertensivePatients

Drug:irbesartan/hydrochlorothiazide


A ClinicalStudy toEvaluateRenalHemodynamicResponses toAliskireninPatientsWithType 2DiabetesMellitus

Drug:Aliskiren;Drug:Irbesartan;Drug:Capt

oprilCompleted

Type 2 DiabetesMellitus

Phase 4 United States 2008-04-01

MycophenolateMofetil(MMF) inPatientsWith IgANephropathy(IgAN)

Drug:irbesartan;Drug:methylprednisolon

e (MP) orprednisone

(pred);Drug:mycophenolate mofetil

(MMF)


IgA Nephropathy Phase 3 China 2007-09-01

A StudyToEvaluateTheDose-RelatedEfficacyandSafety ofPS433540inSubjectsWithHypertension

Drug:irbesartan;Drug:placebo;Drug:PS433540;Drug:PS433540

;Drug:PS433540

Completed Hypertension Phase 2 United States 2008-03-01

IrbesartanandAdhesionMolecules in AF

Drug:irbesartan;Drug:placebo

Unknownstatus

Persistent AtrialFibrillation

Phase 4 Germany 2009-05-01

https://db.yaozh.com/clinical/ZpyZb2li.html

https://db.yaozh.com/clinical/ZpyabWdn.html

https://db.yaozh.com/clinical/ZpyacGJk.html

https://db.yaozh.com/clinical/Zp2SbGhn.html

https://db.yaozh.com/clinical/Zp2UaWFr.html



Evaluation ofEfficacyandSafety oftheDosageAdjustment ofAprovel®(Irbesartan) inHypertensiveOutpatients inCurrentClinicalPractice

Drug:Irbesartan;Drug:Irbesartan

Completed Hypertension Phase 4 Tunisia 2003-02-01

TheEfficacyandSafety ofIrbesartan150/12.5mg and300/25mg inPatientsWith MildHypertension

Drug:IRBESARTAN Completed Hypertension Phase 4 United States 2003-07-01

Randomized,Parallel,Comparison,Double-BlindEfficacy &SafetyStudy ofAPROVELVersusPlaceboinChinesePatientsWithHypertensive TypeII DiabeticPatientsWithMicroalbuminuria

Drug:Irbesartan;Drug:placebo

Completed Hypertension Phase 3 2004-01-01

https://db.yaozh.com/clinical/Zp2Xb2pq.html

https://db.yaozh.com/clinical/Zp2YZ2Fk.html

https://db.yaozh.com/clinical/Zp2YZ2dp.html



IrbesartanEffects onEndothelialDysfunction inHypertensive TypeII DiabeticPatientsComparingAtenolol

Drug:Irbesartan CompletedHypertension;Dia

betes MellitusType 2

Phase 4 Turkey 2003-10-01

Nephropathy InType 2DiabetesandCardio-renalEvents

Drug:currenttherapy;Drug:irbesartan;Drug:ramipril;Drug:hydrochlorothiazide;Drug:furosemide;Drug:amlodipine;Drug:atenolol;Drug:doxazosin;Drug:clonidine;Drug:insulin;Drug:simvastatin;Drug:fibrate;Drug:erythropoi

etin;Drug:aspirin

Unknownstatus

DiabeticNephropathy


Effect oftheAngiotensin IIReceptorAntagonistIrbesartanonBiochemical andFunctional MarkersofEndothelialDysfunction inPatientsWithHypertension

Drug:IRBESARTAN;Drug:Atenolol

Completed Hypertension Phase 4 2002-07-01

Left AtrialRemodelling inHypertension:Effects ofRamiprilorIrbesartan

Drug:ramipril;Drug:irbesartan

Unknownstatus

Left AtrialVolume;Hyperte

nsive HeartDisease;Antihype

rtensiveDrugs;DiastolicFunction;Renin

AngiotensinSystem


https://db.yaozh.com/clinical/Zp2ZZ2Nm.html

https://db.yaozh.com/clinical/Zp2aZ2Jp.html

https://db.yaozh.com/clinical/Zp2aa2ll.html

https://db.yaozh.com/clinical/Z5SRa2Np.html



EfficacyofIrbesartan/Hydrochlorothiazide VersusValsartan/Hydrochlorothiazide in MildtoModerateHypertension

Drug:Irbesartan/hydrochlorothiazide;Drug:Valsartan/hydrochlorothiazide;Drug:Hy

drochlorothiazide


Egypt;HongKong;India;Indonesia;Korea, Republic

of;Malaysia;Morocco;Pakistan;Philippines;Singapore;Taiwan;Thailand;Tunisia;Vietn

am

2007-07-01

Effects ofAliskiren,Irbesartan, and theCombination inHypertensivePatientsWithType 2DiabetesandDiabeticNephropathy

Drug:Aliskiren Completed Diabetes Type 2Phase

1/Phase2

Denmark 2005-09-01

Irbesartan/HydrochlorothiazideNationalTaiwanUniversityHospitalListing

Drug:Irbesartan/Hydrochlorothiazide;Dru

g:IrbesartanCompleted Hypertension Phase 4 Taiwan 2006-09-01

IrbesartanandAtenololinHypertensive HeartDisease

Drug:Irbesartan;Drug:Atenolol

Completed HypertensionPhase

2/Phase3

Sweden 1995-04-01

IPREVENT-IrbesartanInHypertensiveDiabeticPatients

Drug:Irbesartan(Aprovel)

Completed Hypertension Phase 4 Egypt 2006-02-01

https://db.yaozh.com/clinical/Z5SSbWln.html

https://db.yaozh.com/clinical/Z5SVamho.html

https://db.yaozh.com/clinical/Z5SWcGhl.html

https://db.yaozh.com/clinical/Z5WRZ2dq.html

https://db.yaozh.com/clinical/Z5WTaGFi.html



I SELECT -IrbesartanInHypertensivePatientsWith LeftVentricularHypertrophy



Evaluating the LinkBetweenThiazideMedications, theNervousSystem,andDiabetesinIndividuals WithHighBloodPressure

Drug:Chlorthalidone;Drug:Spironolactone;Drug:Eplerenone;Drug:Quinapril;Drug:Ir

besartan

Completed Hypertension Phase 4 United States 2005-01-01

Electrophysiological EffectsofIrbesartaninPatientsWithParoxysmal AtrialFibrillation (AF)


Completed Atrial Fibrillation Phase 3 Spain 2006-07-01

Irbesartan,Ciprofibrate andTheirCombination OntotheEndothelialFunctions

Drug:Irbesartan;Drug:Ciprofibrate

CompletedHypertension;Dy

slipidemiaPhase 4 Hungary 2005-02-01

Effect ofIrbesartanon InsulinSensitivityinChronicHeartFailure

Drug:Irbesartan CompletedChronic Heart

FailurePhase 4 Germany 2004-07-01

https://db.yaozh.com/clinical/Z5WTaGJo.html

https://db.yaozh.com/clinical/Z5WTbmVj.html

https://db.yaozh.com/clinical/Z5WTb2Nl.html

https://db.yaozh.com/clinical/Z5WUZ2Jk.html

https://db.yaozh.com/clinical/Z5WUaWRo.html



EfficacyandSafety ofAliskiren300mgCompared toIrbesartan300mgandRamipril10 mg intheSetting ofa MissedDose forPatientsWithEssentialHypertension.

Drug:Aliskiren CompletedEssential

HypertensionPhase 3

Germany;Switzerland

2006-05-01

I SAVE -Irbesartanin Mild toModerateHypertensivePatients



IrbesartaninChineseHypertensiveDiabeticsWithMicroalbuminuria

Drug:Irbesartan;Drug:Irbesartan


OptimalDose ofIrbesartanforRenoprotection inType 2DiabeticPatientsWithPersistentMicroalbuminuria

Drug:irbesartan CompletedType 2

Diabetes;Microalbuminuria

Phase 4 Denmark 2003-09-01

Irbesartanin Type 2Diabetes

Drug:Irbesartantreatment

Completed

Type 2Diabetes;Microalbuminuria;Hyper

tension

Phase 3

https://db.yaozh.com/clinical/Z5WUa2pq.html

https://db.yaozh.com/clinical/Z5WVZ2hj.html

https://db.yaozh.com/clinical/Z5WVaGZj.html

https://db.yaozh.com/clinical/Z5WWaGdr.html

https://db.yaozh.com/clinical/Z5WWampm.html



ARCHIPELAGO:IrbesartaninPatientsWithAcuteCoronarySyndrome WithoutSTSegmentElevation

Drug:Irbesartan CompletedMyocardial

Ischemia;Hypertension

Phase 3

UnitedStates;Canada;Belgium;France;Germany;Hungary;Italy;Netherlands;

Spain;Switzerland;UnitedKingdom

2006-02-01

APROVE :IrbesartaninHypertension

Drug:Irbesartan Completed Hypertension Phase 4 Algeria 2005-04-01

IrbesartaninHypertension

Drug:Irbesartan Completed Hypertension Phase 4 Turkey 2005-09-01

Evaluation ofIrbesartanonHepaticFibrosis inChronicHepatitisC


CompletedHepatitis C,

ChronicPhase 3 France 2006-10-01

AMISH :AprovelforManagement ofIsolatedSystolicHypertension

Drug:irbesartan andirbesartan-

hydrochlorothiazideCompleted Hypertension Phase 4

Chile;China;Indonesia;Korea, Republic

of;Mexico;Philippines;Taiwan;Thailand

2004-08-01

Irbesartan/Hydrochlorothiazide andIrbesartanin theTreatment of MildtoModerateHypertension

Drug:Irbesartan/hydrochlorothiazide;Dru

g:IrbesartanCompleted Hypertension Phase 3 Taiwan 2005-06-01

https://db.yaozh.com/clinical/Z5WYZ2Nr.html

https://db.yaozh.com/clinical/Z5WZZ2Jm.html

https://db.yaozh.com/clinical/Z5WaaWlo.html

https://db.yaozh.com/clinical/Z5WaamJi.html

https://db.yaozh.com/clinical/Z5Waa2Jq.html

https://db.yaozh.com/clinical/Z5WabGFp.html



AtrialFibrillationClopidogrel TrialWithIrbesartanforPrevention ofVascularEvents(ACTIVEA)

Drug:clopidogrel(SR25990C);Drug:pla

ceboCompleted

AtrialFibrillation;Vascu

lar RiskPhase 3

UnitedStates;Canada;Australia;Argentina;Austria;Belgium;Brazil;Chile;Cze

chRepublic;Denmark;Finland;France;Germany;Greece;Ho

ngKong;Hungary;Italy;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Singa

pore;SouthAfrica;Spain;Sweden;Switzerland;Taiwan;

UnitedKingdom

2003-06-01

AtrialFibrillationClopidogrel TrialWithIrbesartanforPrevention ofVascularEvents(ACTIVE I)


Completed

AtrialFibrillation;Cardi

ovascularDisease

Phase 3

UnitedStates;Canada;Australia;Argentina;Austria;Belgium;Brazil;Chile;Cze

chRepublic;Denmark;Finland;France;Germany;Greece;Ho

ngKong;Hungary;Italy;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Singa

pore;SouthAfrica;Spain;Sweden;Switzerland;Taiwan;

UnitedKingdom

2003-06-01

https://db.yaozh.com/clinical/Z5aRa2pl.html

https://db.yaozh.com/clinical/Z5aRa2pr.html



AtrialFibrillationClopidogrel TrialWithIrbesartanforPrevention ofVascularEvents(ACTIVEW)

Drug:clopidogrel(SR25990C)

TerminatedAtrial

Fibrillation;Vascular Risk

Phase 3

UnitedStates;Canada;Australia;Austria;Belgium;Brazil;Chile;Cz

echRepublic;Denmark;Finland;France;Germany;Greece;Ho

ngKong;Hungary;Israel;Italy;

Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;

RussianFederation;Singapore;Sout

hAfrica;Spain;Sweden;Switzerland;Taiwan;Turkey;United

Kingdom

2003-07-01

Irbesartanfor thePrevention of AtrialArrhythmias andCardiacElectricalRemodeling inPatientsWithHypertension andPermanentPacemakers

Drug:IrbesartanUnknown

status

AtrialFibrillation;Hyper

tensionPhase 3 Canada 2005-12-01

PHARESStudy:Management ofResistantHypertension

Drug:irbesartan,amlodipine and

hydrochlorothiazideCompleted Hypertension Phase 4 France 2005-04-01

https://db.yaozh.com/clinical/Z5aRcGpn.html

https://db.yaozh.com/clinical/Z5aTaWpn.html

https://db.yaozh.com/clinical/Z5aTamli.html



A ClinicalStudy toCompareCombination ofAliskiren+HCTZ toIrbesartan+ HCTZorAmlodipine+HCTZ orHCTZAlone inObeseHypertensive NotResponsive to HCTZ25 mg

Drug:aliskiren Completed Hypertension Phase 3United

States;Germany

2005-01-01

TheRelativeEffects ofOlmesartanMedoxomil,IrbesartanandValsartanon theActivity ofthe BloodPressureControlSystem inHealthySubjects

Drug:Olmesartanmedoxomil;Drug:Irbesartan;Drug:Valsart

an

Completed Healthy Phase 4 2004-11-01

Characterization ofVascularEffects ofAngiotensin II inDorsalHumanHandVeins.

Drug:irbesartan(drug)

Completed Healthy Subjects Germany 2002-01-01

https://db.yaozh.com/clinical/Z5aTbmpj.html

https://db.yaozh.com/clinical/Z5aWamVn.html

https://db.yaozh.com/clinical/Z5aWbmJl.html

Documents

厄贝沙坦药物报告 irbesartan Drug Report · mg、150 mg或300 mg厄贝沙坦。推荐起始剂量为每次150 mg，每日1次，空腹或随餐服用均可。 推荐起始剂量为每次150

厄贝沙坦药物报告 irbesartan Drug Report · mg、150 mg或300 mg厄贝沙坦。推荐起始剂量为每次150 mg，每日1次，空腹或随餐服用均可。推荐起始剂量为每次150